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Abstract
The progression of human chronic periodontitis within periodontal disease has been often
linked to the presence of key pathogens, such as the presence of Treponema denticola, a late colonizer
found in the deepening pockets of the gingival sulcus. This pathogen, as well as its associates
Porphyromonas gingivalis and Tannerella forsythia, are classified as the ‘red complex’ and exist in a
mixed biofilm during infection. It is within this biofilm state that previous transcriptomic analysis
revealed a total of 126 genes that had an increase in their expression by 1.5-fold or greater in T.
denticola. Three of these genes, Tde0626, Tde1701, and Tde2714, were further investigated for their
importance in pathogenicity. Initial bioinformatics analyses suggested putative functions of the gene
products to be a polysaccharide lyase for TDE0626, a bacteriocin-like protein for TDE1701, and a large
formylglycine-generating enzyme (FGE) for TDE2714. Each of the targets were recombinantly expressed
and purified for structural and functional analysis. Both TDE1701 and TDE2714 were able to be
successfully crystallized and X-ray diffraction data were and analyzed. The processed data collected for
TDE1701 resulted an I/σI value of 2.2 at 2.4Å and CC1/2 value of 0.823. Attempts thus far to obtain a
structure of TDE1701 via molecular replacement have been unsuccessful. Similarly, selenomethionine
data were collected for TDE2714, processed to 2.7Å resolution with an I/σI value of 2.2. However, the
data quality was insufficient to determine appropriate phase information to characterize the structure.
In both cases, further crystallization will be required for definitive structural characterization. In order to
test the hypothesis that TDE0626 was a protein responsible for microbial dispersal, attempts at

I

visualization of polysaccharide lyase activity for TDE0626 when incubated with isolates of mixed ‘red
complex’ biofilm was attempted, but unsuccessful, and further investigation will be required. At present,
functional analysis of TDE1701 has yet to be conducted due to the lack of functional hypotheses.
Incubation of TDE2714 with a sulfatase consensus sequence (-LCTPSRA-) revealed an unanticipated
modification to the serine rather than the cysteine residue. The data showed a mass loss of 2.02 g/mol
by ESI-MS/MS on the serine residue suggesting that TDE2714 may be a serine modifying FGE. Further
investigation will be conducted to confirm these results.
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1. Introduction
1.1 – Human Periodontal Disease and Biofilm infections
1.1.1 – Biofilm infections
Human Periodontal disease is an oral polymicrobial disease which affects the tissues
surrounding the teeth, including gums, periodontal ligaments, and alveolar bone(1). The global
epidemiology estimates that between 5-20% of the global human population has a form of severe
periodontitis or its several destructive stages(2). In contrast to other prevailing human diseases,
periodontal disease can be categorized as a polymicrobial disease based on the formation of mixed
bacterial biofilms which left untreated can progress the disease(3). The formation of a biofilm on a hard
surface has been identified to have five main stages which are; attachment, microcolony formation,
biofilm formation, maturation, and dispersal of planktonic bacteria(4). Each of these stages are critical
for the survival of pathogens within a host(4). The attachment and development of microcolonies to
hard surfaces such as the tooth surface allows for planktonic bacteria to gain access to nutrients as well
as promote more frequent genetic exchange and promote the sharing of metabolites(5). As more
microcolonies are formed by the aggregation of planktonic cells and colony growth, the metabolism of
nutrients allows for the secretion of extracellular polymeric substances (EPS) consisting of proteins,
polysaccharides, RNA, and DNA(6). This is general considered to be a biofilm. The formation of the early
biofilm may cause for the further incorporation of other species which contribute to the overall diversity
of the biofilm and subsequent infection(7). Further development leads to the maturation of the biofilm
which is characterized by the three-dimensional development of EPS that contains a variety of systems
1

which are able to aid in the evasion of the immune system(8). The cross-talk between the organisms
within the biofilm allows for horizontal gene transfer in order to induce indirect pathogenicity (IP) in
antibiotic sensitive organisms(9). This is a key exchange component in the proliferation of biofilm
infections as the collective resistance to host defenses allows for the further colonization into the affect
host tissues(10). The recycling of nutrients and by-products within the biofilm also aids in development,
as inaccessible or secondary metabolites can be made readily available to bacteria which in a planktonic
state would have been unavailable. An example of this was shown through the demonstrated utilization
of the lactic acid by-product from Streptococcal metabolism by Aggregatibacter
actinomycetemcomitans(11). As the maturation occurs, the concentration of available or accessible
nutrients for organisms within the biofilm is decreased, which causes for the detachment and dispersal
of planktonic cells in search of new areas of high nutrient concentrations(12). Colonizing new areas
within the host allows for the increased evasion and decreased chance of eradication by the host
immune system(13). The dispersal stage of biofilm infections is a complex stage, consisting of diverse
processes such as the degradation polymeric substances by secreted enzymes, activation of signal
transduction pathways, and release of chemical effectors. To date, no single mechanism for the
dispersal of a biofilm has been discovered(14).

1.1.2 – Periodontal Disease
Human periodontal disease occurs in two stages of infection based on the formation maturation
of a polymicrobial biofilm(15). Periodontal disease can be classified into two main stages depending on
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the severity; gingivitis, and periodontitis(15). The common route of entry for the pathogens is at the free
gingival margin where a host of bacteria attach to the tooth surface and produce a dental plaque or
biofilm(16). It is at this stage that the presence of the bacteria causes for an inflammatory response of
the affected tissues. This inflammation of the gums is referred to a gingivitis and is the beginning stages
of periodontal disease. Consequently, treatments for the early stage gingivitis focus on the removal of
the plaque biofilm which can be accomplished by mechanical displacement through cleaning/flossing
and oral rinses using chlorhexidine or hydrogen peroxide(17). Other methods for removal of the biofilm
involve common dental cleaning practices such as flossing and removal of dental plaque(18). Studies
have shown that the presence of bacteria which produce biologically-active molecules can promote the
proinflammatory response of the host by the increased release cytokines(19). Some common
compounds which are known to cause this are bacterial lipopolysaccharides (endotoxins), chemotactic
peptides, and various protein toxins(19).

If left untreated, the periodontal infection can progress into six more severe forms of the
periodontal disease. The stages of periodontal disease progression are; chronic periodontitis, aggressive
periodontitis, systemic disease periodontitis, necrotizing ulcerative gingivitis/periodontitis,
periodontium abscesses, and combined periodontic-endodontic lesions(20). These latter stages have
been categorized based on their damaging effects on the four main host tissues which are gingiva,
alveolar bone, cementum, and the periodontal ligaments(21). The first stage in the progression of
periodontal disease is chronic human periodontitis which is characterized by the formation of deep
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bleeding pockets within the gingival sulcus(22). It is progressed by the colonizing of pathogens which
originated from the dispersal of the surface biofilm and attached to the tooth neck and roots. As the
biofilm has begun to mature within the gingival sulcus, the degradation of the periodontal ligaments as
well as the resorption of the alveolar bone can be observed(23). It is at this stage where the irreversible
damage first occurs. Unique to chronic periodontitis is that the initiation of the disease can be linked to
the presence of gram-negative bacteria which all are suggested to thrive in maturing biofilm(24). At
present it has been shown that there are both anaerobic and aerobic bacteria which are linked to the
progression of the disease(25). Clinical studies conducted on patients with chronic periodontitis showed
that the affected tissues contained 30 species of bacteria which are associated with the progression of
the disease into more severe symptoms(26). Based on the bacterial association such as the localization
within the biofilm as well as related tissue damage, five distinct colored categorizes were developed
which were; the blue, yellow, and green (early colonizers), the purple and orange (bridging colonizer),
and the red complex (late colonizers)(27). Their localization within the periodontal pocket was also
associated, not directly linked to, their relative pathogenicity within the disease(28). The early colonizers
such as Eikenella corrodens and Campylobacter rectus, located on or near the tooth root surface, were
classified as moderately pathogenic(28). Whereas, the late colonizers at the pocket epithelium such as
Porphyromonas gingivalis and Tannerella forsythia were classified as very highly pathogenic(28). The
presence of the red complex bacteria, which are P. gingivalis and T. forsythia, and Treponema. denticola,
within the deep periodontal pockets has been linked to the progression into the later stage of aggressive
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periodontitis(29). This later stage has been known to be uncommon in human epidemiology, where 1 in
1000 patents with periodontitis developed the aggressive form of the disease(30). The disease
progression is characterized by the localized or the generalized loss of periodontal ligaments which
support the teeth to the alveolar bone. These periodontal lesions are linked to the presence of the red
complex bacteria namely, P. gingivalis, and the spirochete T. denticola as they have the ability to deepen
the periodontal lesions(31). Understanding the progression of chronic periodontitis into the more severe
forms and the development of treatments has been focused around the red complex bacteria and their
contributions to the disease.

1.2 – Treatment and Prevention of Chronic Periodontitis
1.2.1 – Conventional Treatment of Periodontitis
Conventional treatments for chronic periodontitis, in comparison to treatment of gingivitis, have
been known to be more invasive due to the development of deep periodontal pockets. In these cases,
standard brushing and flossing regiments are rendered ineffective when faced with the progressive
destruction of periodontal ligaments and surrounding tissues. In turn, the most common therapy for
chronic periodontitis has been the use of antibiotics which can be coupled with surgical removal of the
developing biofilm and affected tissues. However, due to the wide variety of bacteria present within the
biofilms and the surrounding tissues, either one of these treatments alone have been ineffective in the
complete eradication of the infection. The overuse of antibiotics to treat bacterial infections has led to
the development of widespread resistance in pathogenic bacteria(32). The undesirable development of
resistance has been more pronounced in the treatment of biofilm infections, where pathogens are able
5

to utilize the antibiotics as signal molecules for intra- or interspecies interactions to express genes which
are able to aid in the survival of the pathogens(32). One example of enhanced pathogenicity caused by
the use of antibiotics was found in the increased expression of phosphodiesterases within the biofilm
which was shown to increase cell surface adhesion. This was found to be caused by the activation of the
aminoglycoside response factor which could bind to sub-inhibitory concentrations (SICs) of
aminoglycoside antibiotics(33). The ability for pathogens to adapt to treatment against antibiotics within
biofilms has been also linked to the gradient concentrations of nutrients from the surface of the biofilm
to the center(34). This has been shown to be caused by the dormant bacteria which play key roles in the
tolerance of antibiotics(35). Studies have shown that the increased expression of regulatory proteins in
Pseudomonas aeruginosa is linked to the conversion of resistant and sensitive forms and can be
impacted by the concentrations of antibiotics(36). Similarly, the increased IL-17 antibody expression in
diabetes patients showed to affect the pathogenicity of oral pathogens(37). Other factors which can
affect the antibiotic treatment of biofilms has been known to be due to the increased expression of
multidrug resistance (MDR) efflux pumps(38). The efflux pumps are highly active within a biofilm and
can render the treatment of certain antibiotics ineffective in eradicating the total biofilm(39). In
addition, in vitro and in vivo experimentation on streptococcal biofilms showed an increase in the
minimal inhibitory concentration (MIC) for antibiotics of 10-1000 times relative to planktonic
Streptococcal(35). Although the use of antibiotics alone may be ineffective in eradicating the whole
biofilm, they are able to affect the planktonic bacteria and aid in the decrease of biofilm dispersal(40).
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Surgical endodontic treatment of periodontitis has been one of the most effective and widely
used methods for treating the infection. The use of scaling and rooting to remove the deep pocket
biofilms has been employed to treat the periodontal lesion formed during the infection(41). However, a
key challenge in the microsurgery is the requirement of extensive bone and tissue grafting postsurgery(42). Negative treatment outcomes for the use of endodontic surgery have been the main cause
for concern post-surgery(43). This is due to the re-development of biofilm infections and tissue damage,
resulting in retreatment procedures that can pose irreversible damage to the teeth and tissues(44).
Investigations into the coupling of both surgical and non-surgical treatments have proven to be the most
effective to date(43). However, significant recovery time, due to accidental nerve damage, and potential
relapse of infection has been commonly seen in patients treated(45,46). In short, the conventional
treatment methods for chronic periodontitis require extensive treatment with the potential for
irreversible damage to patients. This has led to alternative treatments to be employed which could
significantly reduce the irreversible damage as well as better eradicate the biofilm infection.

1.2.2 – Alternative Treatments for Disrupting Biofilm Formation
A more recent technique for biofilm infection eradication has been the targeting disruption of
the quorum sensing system present in the biofilms. This system has been found to be employed by the
bacteria within a biofilm to regulate cooperative activities as well as the respond and adapt to the
changing environment surrounding the biofilm. The system hinges on two main categories of molecules,
N-acyl homoserine lactones (AHLs) and oligopeptides, which are expressed and secreted into the
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extracellular matrix. These molecules are utilized by other bacteria for “cell-cell communication”. This
communication allows for the bacteria to coordinate the levels gene expression. The increased
expression of quorum effector molecules has been proposed to be key in the division of bacterial labor
as well as the repression of growth in certain species of bacteria for nutrient availability. The secreted
oligopeptides which are called autoinducers, are used as signaling molecules for the quorum system to
enable bacterial competence and virulence(47). The importance of quorum sensing systems for biofilm
formation, survival, and maturation has posed as a good target for the development of inhibitory
molecules(48). A key target for quorum sensing inhibition is AHL synthase, which synthesizes AHLs for
the system. Compounds such as L-S-adenosylcysteine and D/L-S-adenosylhomocysteine, have been used
for the inhibition and quenching of the quorum sensing system(49). Structural analogues of the secreted
oligopeptides has also been shown to aid in the inhibition of the system(50).

1.3 – Factors Affecting Pathogenicity
1.3.1 – Role of Virulence Factors in Biofilm
The formation and survival of a biofilm requires the need for expressed factors which can aid in
the individual survival of the bacterium as well as the maintenance of the biofilm as a whole. These
survival factors are commonly secreted into the matrix or the surrounding tissues where they can
perform a host of different functions. The main function of a bacterial virulence factor is to increase the
pathogenicity of the organism by accomplishing one or more of the following: colonization,
immunoevasion, immunosuppression, and nutrient acquisition. Investigations into these systems such
as the survivability of the pathogens within a host has allowed for new insight into the field of drug
8

therapy. This more specified approach to treatment has been shown to be advantageous in eradicating
essential pathogen species while maintaining the host microbiome, in comparison to traditional
antibiotics(51). In order for a successful long-term biofilm infection to form, the pathogens must express
and utilize adhesion molecules and proteins, called adhesins(52). Most commonly found adhesins in
gram-negative dominant biofilms, such as in periodontitis, are the trimeric autotransporter
adhesins(53). These are outer membrane proteins have been known to bind to the epithelial cells by the
attachment of the N-terminal head domain to structural elements such as collagen and fibronectin(54).
These adhesins play a key role in the formation of a bacterial biofilm and may be a target for future drug
development(55). Similarly, the initial survival of the long-term biofilm has been known to require the
appropriate factors which can suppress and evade the host immune system. The activation of the host
immune system produces immunoglobulin antibodies which can bind to surface antigens on the
pathogen for destruction(56). It has been shown that pathogens within a developing biofilm produce
immunoglobulin proteases as virulence factors in order to evade the host immune system(57). The
evasion of the immune system has also been associated with the suppression of the host immune
system by the interactions between the host immune cells and the pathogens. The most studied
immunosuppression methods for pathogens is to prevent phagolysosome biogenesis and the inhibition
of cellular autophagy(58). These factors were first identified in the interaction between Mycobacterium
tuberculosis with host macrophages(59). There have also been studies that show some pathogens
exhibit the ability to inhibit antigen presentation to immune cells(60).
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Of the host of virulence factors which can contribute to the pathogenicity of the organisms, the
most frequently studied proteins/enzymes are critical for the reliable obtaining of nutrients, further
colonization and dispersal, as well as contribute to the prolonged evasion of the host immune
system(61). These contribute to the progression of destructive infections as they are essential for the
long-term survival of the pathogens and biofilm. One means of the survival for bacteria is obtaining
inaccessible nutrients as metabolites as the availability of common metabolites is diminished by other
present pathogens(62). A class of enzymes commonly associated with the further colonization of
pathogens in a biofilm infection is the polysaccharide lyases(63). These enzymes are secreted into the
extracellular matrix where N-acetyl-glycosaminoglycans (GAGs) such as hyaluronan and heparin sulfate
are present. It is here that the enzymes have been known to degrade the polysaccharides via an anti-βelimination reaction that cleaves the α-(1,4)-linked uronic acids to produce an unsaturated hexenuronic
acid residue and a reducing end(64). The degradation of GAGs within a biofilm has been shown to be a
key step in the dispersal of the biofilm. There have also been studies which showed the degradation of
GAGs by polysaccharide lyases was involved in bacterial gluconeogenesis(65). This has been shown by
using co-expressed ABC-transporter proteins to bring the hexenuronic acid residues into the cells to
generate glyceraldehyde 3-phosphate (G3P)(66). This involvement of polysaccharide lyases as well as
other lyases reveal the multi-faceted function of these essential factors.

Similarly, access to host nutrients is of importance for pathogenic infection as there are higher
concentrations of essential metabolites and nutrients available within the host tissue. This due to the
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decreased amount of available nutrients within a biofilm. It has shown that some pathogenic bacteria
such as Streptococcus agalactiae and T. denticola express large amounts of hemolytic proteins called
hemolysins(67,68). These enzymes are able to agglutinate and lyse erythrocytes in the invaded host. In
order to do so, the hemolysins are extracellularly secreted into the surrounding tissues where the host
cell membranes are degraded via pore formation. Studies showed that there are various methods in
which these hemolytic proteins can function, such as the oligomerization of toxin monomers to make
hydrophilic channels in the membrane(69), as well as the production of hydrogen disulfide (H2S) which
can produce hemolytic activity(70). An example of the hemolytic activity of H2S was found in the
expression of cystalysin, which is a 46kDa Cβ–Sγ lyase from T. denticola(71). The Cβ–Sγ lyase
demonstrated measurable hemolytic activity on erythrocytes in vitro. The data was coupled with prior
information showing that >2 mM concentration of H2S have been identified within periodontal
pockets(71). This detection leads to the suggestion that hemolytic proteins expressed by pathogens can
be used in order to obtain nutrients from the host cells as well as aid in the further progression of the
disease.

1.3.2 – Development of New Treatments for Chronic Periodontitis
In order to develop new treatments for chronic disease that differ from the conventional
methods, the identification of essential factors for important pathogens is required. Several methods
have been employed over the years to identify new targets for drug design that can be either based on
genomic analysis, transcriptomic analysis, as well as proteomic analysis of the pathogens. These
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methods have been used to generate a collective list of the best candidates for drug design. The
parameters for candidates are based on how essential the target is to pathogen survival in the host,
effect on the host immune system, cooperative ability with other pathogens, development of severe
symptoms, as well as general contribution to the progression of disease(72). Once the targets are
identified by the initial techniques, biochemical investigations must be conducted in order to give a
complete characterization of the target as well as an accurate prediction of its role and importance in
the pathogen and disease. Common techniques for analysis include, but are not exclusive to,
bioinformatics, X-ray crystallography, nuclear magnetic resonance, enzymatic kinetic analysis, and
subsequent development and testing of structural substrate analogues(73). Together these methods
were used in this research project for the characterization of specific targets.

For this research project, the organism T. denticola was focused on, based on its role in the later
stages of chronic human periodontitis. T. denticola is a Gram-negative obligate anaerobic spirochete
that has been found in high quantities within maturing periodontal pockets and periodontal
biofilms(74). The organism is closely associated with the other members of the red complex and has
been found to aid in the progression of periodontitis(74). In order to gain insight into important factors
for pathogen survival function, previous work done by the Reynolds group identified 126 transcripts that
were found to have a 1.5-fold increase in expression when T. denticola was grown in a dense
monoculture. This phenomenon is considered to be an upregulation of genes(75). These values were
compared to the expression levels of the planktonic state of T. denticola. This information was obtained
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by micro array assays to isolate the total RNA of T. denticola in the biofilm. Of the 126 genes, a subset
was identified of the upregulated genes which possessed similarities to prophage genes, as well as toxinantitoxin protein systems(75). The presence of the prophage genes within T. denticola suggested that
the pathogen was associated with bacteriophage infection as the genes were identified as a part of the
genome(76). Furthermore, T. denticola contained a vast number of uncharacterized hypothetical
proteins that had similarly increased expression within a dense monoculture. Based on the data shown
by the transcriptomic analysis, three genes further investigated for their role and importance in T.
denticola. The selected genes were; tde0626, tde1701, and tde2714. These genes were not selected by
chance, but rather were selected based on upregulation and the predicted extracellular localization of
the gene products. Each of the genes were recombinantly expressed in an Escherichia coli expression
system and purified for biochemical analysis.

1.4 – Research Objective and Hypothesis
The main objective for each of the targets; TDE0626, TDE1701, and TDE2714 was to determine
the structure and function of the recombinantly expressed protein to gain insight into their role in T.
denticola. Based on the lack of structural and functional information of these three gene products,
biochemical techniques, such as X-ray crystallography and functional assays will be conducted. The
annotation of these gene products will be used to investigate if these targets play a specific role in
within T. denticola and its involvement in the progression of chronic periodontitis. The identification of a
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contribution to the pathogenicity of T. denticola will be discovered by comparison of the results to
known gene products that play a role in the pathogenicity of other microbes.

The long-term objective would be accomplished primarily by the use of X-ray crystallography to
generate accurate structural models as well as developing and testing functional assays and protocols
which would be able to give insight into the function of the three targets.

The first short term objective was successful recombinant expression and purification of soluble
protein from each of the three targets, as well as structural and functional prediction based on
bioinformatics analysis. Once accomplished, the next objective was to successfully crystalize each of the
proteins and obtain good quality X-ray diffraction data. This was then used to generated structural
models based on molecular replacement and structural refinement. Afterwards the objective was to
identify potential substrate binding of each of the protein targets by co-crystallization of mutants
generated by site-direct mutagenesis. The last objective was to functional characterize each of the
proteins by developing kinetic assays derived from the bioinformatics analysis.

2. Materials and Methods
2.1 – Materials
2.1.1 – Bacterial Transformation and Plasmid Extraction
Custom genes for targets TDE0626, TDE1701, and TDE2714 were codon-optimized for
expression E. coli, housed in pET21b (+) vectors, were ordered from Bio Basic Canada Inc. (Markham,
ON). Calcium chloride dihydrate, tryptone, and yeast extract were also from Bio Basic Inc. Competent
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NEB 5-alpha E. coli cells and BL21 (DE3) E. coli cells were ordered from New England BioLabs Inc.
(Ipswich, MA, USA). Sterile nuclease-free water (nuclease, RNase, DNase, and Protease-free), nutating
mixer: variable speed, and the Fisherbrand minicentrifuge Spout were ordered from Fisher Scientific
(Hampton, NH, USA). Miniprep plasmid extraction kit, QIAprep Spin Minprep Kit was from Qiagen Inc.
(Toronto, ON). The Analog Dry Block Heater and the Clinical 100 Laboratory Centrifuge were from VWR
International LLC. (Mississauga, ON). Reagent grade sodium chloride and ampicillin sodium salt were
ordered from BioShop Canada Inc. (Burlington, ON). 1.5mL microtubes, 92x16mm petri dishes, and
13mL 100x16mm tubes were from Sarstedt Canada (Des Grandes Prairies, QC). The MaxQ 4000
Benchtop orbital shaker was from Thermo Fisher Scientific (Mississauga, ON).

2.1.2 – Bacterial Growth and Recombinant Expression
Large bacterial cultures were grown in two-liter Pyrex® Shaker flasks with extra deep baffles
from Sigma Aldrich Canada (Oakville, ON). Nalgene centrifuge tubes (50mL) were also ordered from
Sigma Aldrich Canada. Large volume centrifuge Avanti Jxn-26 Centrifuge, the J-Lite® Series JLA-8.1 rotor,
and the J Series JA-20 rotor were from Beckman Coulter Canada Inc. (Mississauga, ON). BioUltraPure
grade Isopropyl β-D-1-thiogalactopyranoside (IPTG), reagent grade trisaminomethane (Tris),
Biotechnology grade Triton® X-100, ACS reagent grade magnesium chloride hexahydrate, hen egg white
lysozyme, sucrose, and reagent grade glycerol were all ordered from BioShop. Deoxycholic acid sodium
salt, DNase I, hydrochloric acid, and ultra-pure DL-dithioreitol were from Bio Basic Inc. The GENESYSTM
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10S UV-Vis Spectrophotometer was from Thermo Fisher Scientific. The semi-micro visible acrylic
disposable cuvettes and the 50mL 114x28mm tubes were from Sarstedt Canada.

2.1.3 – Immobilized Metal Affinity Chromatography
Econo-Column® Chromatography columns and the Econo- Gradient Pump were both ordered
from Bio-Rad Laboratories Canada Ltd. (Mississauga, ON) . HisPurTM Ni-NTA resin was from Thermo
Fisher Scientific. Reagent grade imidazole, glacial acetic acid, and ethylenediaminetetraacetic acid
(EDTA) disodium salt dihydrate were from BioShop. nickel (II) chloride Hexahydrate was ordered from
Bio Basic Inc. Solid sodium hydroxide and guanidine hydrochloride were ordered from VWR
International LLC. Plastic tubes (15mL) were from Sarstedt Canada.

2.1.4 – SDS-PAGE and Dialysis
BioUltraPure sodium dodecyl sulfate (SDS), 40% acrylamide, 2% bis-acrylamide,
tetramethylethylenediamine (TEMED), and Coomassie Brillant Blue G-250 were all purchased from
BioShop Inc. Power Pac Basic, Mini-Protean Tetra System, and the precision plus proteinTM dual color
ladder were from Bio-Rad Laboratories Canada Ltd. Ammonium persulfate (APS) was ordered from
Fisher Scientific. Bromophenol blue was from Sigma Aldrich Canada. Glycine was ordered from Bio Basic
Inc. 95% ACS methanol was from CFS Custom Chemical Solutions and the Molecular Imager® Versa Doc
MP System was purchased from Bio-Rad Laboratories Ltd.

The 50mm Fisher Regenerated cellulose dialysis tubing and the FisherbrandTM octagon SpinBar
magnetic stirring bars were ordered from Fisher Scientific. Reusable plastic 2L graduated beaker was
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from Owens Corning Canada (Guelph, ON). The Thermolyne Type 1000 heated stir plate was from Sigma
Aldrich Canada.

2.1.5 – Anion Exchange Chromatography and Dynamic Light Scattering
Fast Protein Liquid Chromatography (FPLC) instrument was the ÄKTA Pure from GE Life Sciences
Canada (Mississauga, ON) as well as the HiTrapTM Q FF anion exchange chromatography column (5mL).
Ethyl alcohol (95% v/v) and the Amicon Ultra-15 centrifugal filter units were ordered from Sigma Aldrich
Canada. micro UV 1.2mL disposable cuvettes were purchased from Sarstedt Canada. The Allegra X-14R
centrifuge and the SX4750 Swinging-Bucket Rotor were from Beckman Coulter Canada Inc.

Dynamic light scattering (DLS) was conducted with the DynaPro PlateReader-II and Dynamic
7.1.9 program from Wyatt Technology Corporation (Santa Barbara, CA, USA). Black polystyrene
microplate (96-well) was from Owens Corning Canada.

2.1.6 – Crystallization and X-Ray Diffraction Analysis
The MCSG crystallization Suite for MCSG-1,2,3, and 4 crystal screens were from Anatrace Inc.
(Maumee, OH, USA). PACT PremierTM HT96 crystal screen and the 55L Bench Top Incubator (fullyprogrammable) were from Molecular Dimensions Ltd. (Maumee, OH, USA). Crystal Screen 1 and 2,
IndexTM HR2-144 crystal screen, and HR2-110 crystal screen were purchased from Hampton Research
(Aliso Viejo, CA, USA). Crystal Gryphon, Intelli-Plate 96-3 3-well sitting drop plates, and 0.2mL protein
tubes were purchased from Art Robbins Instruments (Sunnyvale, CA, USA). HD Clear packaging tape was
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from ShurTech Brands, LLC (Avon, OH, USA). SteREO Discovery.V8 stereomicroscope was purchased
from Carl Zeiss Canada Ltd. (North York, ON).

TC Plate 24 well cell culture plates were ordered from Sarstedt Canada. Siliconized glass circle
cover slides (18mm) and monodisperse polyethylene glycol (PEG) 3350 were ordered from Hampton
Research. Reagent grade glycerol, ethylene glycol, and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) free-acid were all purchased from BioShop Inc. Polyethylene glycol mono-methyl ether 550
and polyethylene glycol 6000 were ordered from Sigma Aldrich Canada. Sodium nitrate was from Bio
Basic Canada Inc. High vacuum grease was purchased from Owens Corning Canada.

Reusable Goniometer Base B1A and 100, 300, 600, 1000µm Dual-Thickness MicroLoops LD were
purchased from MiTeGen, LLC (Ithaca, NY, USA). Industrial grade liquid nitrogen was ordered from
Praxair Canada Inc. (Kitchener, ON). XT20 Cryogenic Storage Tank was purchased from Taylor-Wharton
(Bolivar, OH, USA). Cassette Loading and shipping kit, ALS Pucks, and shipping cane was purchased from
Crystal Positioning Systems (Jamestown, NY, USA). The 2.9GeV Storage ring Synchrotron was used at the
Canadian Light Source Synchrotron (Saskatoon, SK).

2.1.7 – Functional Assays and Analysis
High purity grade peptide (>95%) – LCTPSRA – was ordered and synthesized from GenScript
(Burlington, ON). Silica gel 60 aluminum thin-layer chromatography (TLC) sheets, Rectangluar TLC
developing tank, ACS reagent ninhydrin, 99.8% pyridine anhydrous were purchased from Sigma Aldrich
Canada. ACS grade sodium phosphate dibasic and 1-butanol were ordered from BioShop Inc. Centivap
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concentrator was from Labconco (Kansas City, MO, USA). Precision Model 16 Gravity Convection Lab
Oven from GCA. Bruker AmaZon SL LC-MSn used for electron spray ionization mass spectrometry (ESIMS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) were from the University of
Guelph. Isolated and purified biofilm of mixed culture of red complex bacteria (T. Forsythia, P. gingivalis,
and T. denticola) were obtained by Christopher Bartlett and Sidney Nechacov from the Slawson Lab
(Dept. of Biology, WLU).

2.2 – Methods and Experimental Design
2.2.1 – Bacterial Transformation and Recombinant Protein Expression
Plasmids housing the three target genes TDE0626, TDE1701, and TDE2714 were transformed
into both calcium competent NEB 5-alpha and BL21 (DE3) E. coli cells. Each of the genes were
synthesized within a pET21b vector and 40µL of nuclease-free water was added to the 4µg of custom
genes to make a working stock of each plasmid (Figure A5 in Appendix). These were then mixed via a
nutating mixer for 30 minutes prior to transformation. The transformation of the custom genes was
conducted by incubating 1µL of the plasmid with 50µL of the competent cells in sterile 1.5mL
microtubes. The incubation was at 4oC for 30 minutes and then placed at 42oC for one minute for heat
shock using the heat block. The cells were then placed back at 4oC for 3 minutes and then 200µL of
lysogeny broth (LB) (100mL stock containing 1g of tryptone, 0.5g of yeast extract, and 1g of NaCl), was
added to the cells. These were placed in the benchtop orbital shaker for one hour at 240rpm at 37oC.
Once the bacteria were sufficiently grown in the LB, the cells were spread on 100µg/mL ampicillin
containing agar plates and incubated overnight at 37oC. This allowed for selective growth.
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The following day, a single colony of bacteria was chosen and grown in 10mL of LB containing
100µg/mL of ampicillin. The 10mL culture of bacteria was grown for 16 hours at 37oC and 240 rpm
overnight. Each of the transformed cell strains for the three targets were made into freezer stocks (for
long term storage) by adding 25% glycerol into a sample of the cultures. These were then frozen and
stored at -80oC.

For the transformed 5-alpha E. coli, the cell culture was centrifuged at 12,000xg for 5 minutes
and pelleted for a miniprep plasmid isolation. Each of the three different plasmids were miniprep via the
protocol stated in the QIAprep Spin Minprep Kit. Once the isolated plasmids were collected, the
concentration of dsDNA was found via UV readings at 260nm and 280nm (for purity) using the BioTeck
Cytation 5 image reader. The isolated plasmid DNA for each of the three targets were stored at -20oC.

For transformed BL21 (DE3) E. coli cells, the -80oC cell cultures were used to inoculate 1L of LB
broth containing 100µg/mL of ampicillin in 2L shaker flasks. The large cell cultures were then incubated
at 37oC and 240 rpm until an optical density at 600nm (OD600) of 0.6 was reached. To test the OD600, a
sample of each of the cultures were read using the GENESYS 10S UV-Vis spectrophotometer. Once the
OD600 was approximately 0.6, a final concentration of 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG)
was added to each of the large cultures, to induce protein expression. The cultures were the incubated
at 16oC and 160 rpm for 16 hours.

The induced BL21 cells were harvested by centrifugation using the Avanti Jxn-26 centrifuge at
5,000rpm for eight minutes at a temperature of 16oC. The supernatant was decanted, and the cell
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pellets were retained for osmotic shock chemical lysis and sonication. It was standardized that two cell
pellets of the same recombinant target would be used in one isolation and purification. Cell pellets
which were not immediately used were stored at -20oC for future experimentation.

For the lysis of TDE0626, ultrasonic frequency sonication was conducted due to the formation of
an large insoluble fraction when chemically lysed. The harvested cell pellets of TDE0626 were suspended
in 100mM sodium phosphate at pH 8.0 and subjected to 20 second pulse intervals at an amplitude of
40% and 30 second off intervals in order to minimize the heat energy given to the lysed cells and protein
contents. The lysate of TDE0626 was centrifuged at 15,000xg for 35 minutes to separate the insoluble
cell components formed during the sonication. All steps of sonication protein isolation were done on ice
to minimize heat denaturation of the recombinant protein.

The harvested cell pellets of TDE1701 and TDE2714 were treated with 730mM sucrose in a
buffered solution containing 50mM Tris-HCl pH 8.0 and 300mM sodium chloride. The salt was used in
order to maintain the solubility of the isolated protein whereas the sucrose was used for hypo-osmotic
shock cell disruption. As the bacteria experience a change in the osmotic pressure, water flows into the
cells which causes for the rupture of the cell membrane and release of cellular contents. Once 25mL of
the sucrose solution was added to the cell pellets, the slurry was stirred using a magnetic stir bar on ice
for 10 minutes. In order to digest the cellular matter from the lysate, 10 milligrams of egg white
lysozyme were added to the stirring lysate for another 10 minutes. After which, two equivalent volumes
of a 24mM deoxycholic acid solution (50mM Tris-HCl pH 8.0 and 300mM NaCl) was added to the
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resuspended lysate. The solution also contained 15mM Triton X-100 which was a non-ionic detergent
used to solubilize the cellular membranes and other exposed hydrophobic components. The lysate again
was stirred for an additional 10 minutes on ice. Lastly, 2.6µg/ml of DNase I was added to the lysate in
order to digest the DNA present in the lysate and lower the viscosity of the lysate as well. 5mM of MgCl2
was also added as a cofactor for the DNase I. The lysate was stirred for another 10 minutes to ensure
complete digestion of all cellular components which were not the recombinant protein. The lysate was
centrifuged at 15,000xg for 35 minutes to separate the insoluble cell debris from the soluble
recombinant proteins.

For all three targets, the crude recombinant protein solution was transferred to a 50mL plastic
tube and stored at 4oC. A small sample of the insoluble pellet was taken for each of the targets after
centrifugation and resuspended in 50µL of ultra-pure water for analysis. This allowed for the sample to
be properly loaded in the polyacrylamide gel. A 50µL sample of the supernatant was also taken for
further analysis via SDS-PAGE.

2.2.2 – Nickel Nitrilotriacetic Acid Immobilized Metal Affinity Chromatography
Initial purification of the crude protein extract was conducted via nickel-nitrilotriacetic acid (NiNTA) immobilized metal affinity chromatography (IMAC). This was due to the presence of a six-histidine
tag on all the recombinant targets located at the C-terminus. Approximately 5mL of the HisPur Ni-NTA
resin was loaded into the Econo-Column® Chromatography columns which was stored in 20% (v/v) ethyl
alcohol. Once the alcohol was washed out by several column volumes of water (~50mL per CV), the
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crude protein extract for each of the targets was added to resin. The resin and protein extract were
incubated on ice for one hour by a shaker rocker instrument. Once the resin was thoroughly mixed, the
slurry was placed into the chromatography column and allowed to flow though via gravity filtration. The
sample collected from the initial flow-though was stored at 4oC for further analysis. One column volume
of ultra-pure water was run through the column in order to wash out any weakly bound proteins or
other contaminants. Two separate buffering solutions were prepared for the IMAC. These were a 5mM
imidazole wash solution, and a 500mM elution solution where each solution also contained 300mM
NaCl and 50mM Tris-HCl pH 8.0. It should be noted that 50mM sodium phosphate buffer pH 8.0 was
used for the purification of TDE0626 instead of Tris. A plunger apparatus was lowered into the column
to a height of 10mm above the resin bed and vacuum sealed for consistent pressure during the IMAC. A
low concentration of imidazole was used as a wash solution as it could compete with the binding of
weakly associated proteins and not the target protein. This was conducted at a volume of 50mL at a flow
rate of 4mL per minute and collected in a conical tube. A step gradient of increasing imidazole
concentration was performed by the mixing of the wash solution and the elution solution. The flow rate
was 4mL/min and fractions were collected every 10mL (in 15mL conical tubes) for corresponding to a
25mM concentration increase of imidazole. The imidazole gradient ranged from 5mM imidazole up to
250mM imidazole. Once the gradient elution was completed, a 10mL fraction was collected of 100%
elution buffer over the column. The gradient and mixing were all conducted by the Econo- Gradient
Pump and all fractions collected were stored at 4oC. In order to clean the column and resin of all non-

23

eluted proteins, a column volume of 10%(v/v) acetic acid was run through the column flowed by a
column volume of 0.5M NaOH. Ultra-pure water was run in-between the cleaning steps. To ensure
proper storage and longevity of the column and resin, the resin was stored under one bed volume (5mL)
of 20% (v/v) ethyl alcohol.

2.2.3 – Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Dialysis
In order to evaluate the relative successfulness of the recombinant protein expression, isolation,
and purification each of the collected fractions from the IMAC were subjected to SDS-PAGE and dialysis.
This also included the samples collected from the cell debris pellet and the flow-through sample of the
IMAC. The polyacrylamide gel used consisted of a 12% (w/v) separating gel and 4% (w/v) stacking gel.
The consistency of the gel was made from a mixture of 40% acrylamide and 2% bis-acrylamide. To
solidify the gel, 50µL of 10% ammonium persulfate (APS) and 10µL of tetramethylethylenediamine
(TEMED) were added to the unpolymerized gel layers. Once the gel was cast and polymerized, 20µL
sample from each fraction was transferred to a 1.5mL microtube. Each sample was then treated with
5µL of a 5X SDS sample buffer which contained sodium dodecyl sulfate (SDS), and dithiothreitol (DTT)
and glycerol. These samples were heated to 95oC for five minutes to ensure sufficient protein
linearization and binding of SDS to the protein strands. Once the samples were cooled, they were loaded
beside the precision plus proteinTM duel color ladder for protein visualization. Electrophoresis was
conducted in 1X SDS running buffer which contained 25mM Tris-HCl pH 8.0, 200mM glycine, and
3.46mM SDS. The chamber was filled to the equivalent of two gels due to leaking which occurred during
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the electrophoresis procedure. Electrophoresis was run at 180 volts and 400mA for 45 minutes which
may have also been run for a shorter period if the dye front was approximately 1cm from the gel
bottom. For staining of the gel, a Coomassie Brillant Blue G-250 staining was used, which was able to
bind to the retained protein bands. The stain also included glacial acetic acid and methanol which
required heating in a microwave to bind to the protein in the acrylamide gel. The gel and stain where
heated for 30 seconds in a microwave before placing destaining solution (containing larger
concentrations of methanol and glacial acetic acid) onto the gel to remove the excess Coomassie which
did not bind to the protein. Once the gel was sufficiently destained, an image of the gel was taken using
the Molecular Imager® Versa Doc MP System at a focal number of 11 and optimized exposure of 1
second on a white background.

Based on the acrylamide gel results, the protein samples which contained a large amount of
“pure” protein were pooled together in order to prepare for dialysis. Dialysis was conducted as the
purity of the isolated protein samples were not sufficient to merit direct crystallization due to the
presence of contaminants at various sizes. A secondary purification step was conducted using anion
exchange chromatography; however, the presence of imidazole in the pooled protein sample would
impede the anion exchange at the pH used (8.0). Therefore, the protein samples were pooled into a
50mm Fisher Regenerated cellulose dialysis tubing which had a molecular weight cut-off at 6-8kDa.
Since all the targets were over 30kDa in molecular weight, it was possible that the protein would remain
within the tubing while the imidazole would be removed to the surrounding solvent through osmosis.
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The protein-containing tubing was placed initially into two liters of water and stirred gently for two
hours. The tubing was then removed for the water and placed into freshly prepared buffering solution
(either 50mM Tris-HCl pH 8.0 for TDE1701 and TDE2714 or 100mM glycine pH 9.6 for TDE0626). The use
of 100mM glycine pH 9.6 for TDE0626 was due to the amount of precipitation which occurred when
TDE0626 was dialyzed into 50mM Tris-HCl pH 8.0. It was found by multiple samplings of TDE0626
dialyzed in various buffers that the protein solution was most stable and soluble in 100mM glycineNaOH pH 9.6. Dialysis into the fresh buffer occurred overnight (~16 hours) at 4oC.

2.2.4 – Anion-Exchange Chromatography and Dynamic Light Scattering (DLS)
Further purification of each of the targets was required and was achieved through the use of
anion-exchange chromatography. Prior to anion exchange, dialyzed TDE0626 sample was removed from
the dialysis tubing and centrifuge at 12,000xg at 10oC for 10 minutes in order to remove any protein
aggregates. The decanted protein sample was placed over an ÄKTA Pure FLPC and the UNICORN 6.4
Workstation program from GE which had a HiTrapTM Q FF anion exchange column. For both TDE1701
and TDE2714, the wash buffer contained 50mM Tris-HCl pH 8.0 buffer and the elution buffer contained
50mM Tris-HCl pH 8.0 with 1M NaCl. For TDE0626, the wash buffer contained 100mM glycine-NaOH pH
9.6 and the elution buffer contained 100mM glycine-NaOH pH 9.6 with 1M NaCl. The protein sample
line (position A7) was purged in ultra-pure water prior to sample application.

After the column cleaning (using water, high salt concentration, and wash buffer equilibration),
a pre-programmed protocol for anion-exchange was initiated for each of the recombinant proteins. The
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protocol contained a gradient elution for the bound protein with increasing NaCl concentration which
and elution fractions were collected into 15mL sterile conical tubes. The absorbance increase at 280nm
due to the elution of the purified protein was monitored in real-time based on a gradient program. Once
the fractionation was completed and 100% elution buffer was run over the column, the protocol
finished by removing the excess salt and storing the column in 20% filtered ethyl alcohol.

Prior to the crystallization attempts for the purified recombinant proteins, the selected fractions
from the anion-exchange chromatography were concentrated to 5mg/mL using an Amicon Ultra-15
Centrifugal filter with a molecular cutoff of 10kDa. The fractions were pooled together based on the
peak absorbance reading from the anion-exchange chromatography. The samples were then centrifuged
at 4000xg for 15-minute intervals at 4oC using a Beckman SX4750 swinging-bucket rotor. The flowthrough was collected and the retained protein sample was measured for the concentration. The
concentration was measured based on the absorbance of tryptophan residues in the protein samples at
280nm. The UV-Vis spectrophotometer was blanked using 1mL of ultra-pure water in a disposable UV
cuvette and obtaining a baseline reading for the water. The concentrated protein sample (5µL) was then
added to the water blank and a UV spectra range of 260-300nm was measured. To calculate the protein
concentration, Beer–Lambert law was used using the formula A = ε*C*l (absorbance = molecular
extinction coefficient * concentration * path length). The molecular extinction coefficient for each of the
proteins was calculated via Protparam when all the cysteines form disulfide bridges. The extinction
coefficients at 280nm, for each protein were 16390M-1cm-1 for TDE0626, 30620M-1cm-1 for TDE1701,
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and 170225M-1cm-1 for TDE2714. In order to obtain the concentration in mg/mL, the conversion of
mol/L calculated to mg/mL was as follows;

Conc. (mg/mL) = [conc. (mol/l) * MW (g/mol) * (1L/1mL) * (1000mg/1g)] * (1005µL/5µL)

Absorbance readings were conducted for all three of the recombinant proteins to yield
concentrations in the units of mg/mL which was the standard units used for crystallization. Further
analysis prior to crystallization was the use of DLS which was able to determine the
oligomeric/aggregate state of the protein samples. To perform DLS analysis, a 40µL sample of the
5mg/mL protein sample was placed into a 96-well black polystyrene microplate in triplicates (if
possible). Protein samples were carefully added to the wells to ensure no bubbles were present. Once
each sample was added to the plate, the plate was immediately placed into the DynaPro PlateReader-II
at a constant incubation temperature of 25oC. Settings for the DLS reading were programmed into the
Dynamic 7.1.9 program. The plate reading would record samples in succession where each reading of a
well had 20 images collection taken with an acquisition time of 5 seconds. Data were then averaged and
analyzed via generation of a percent mass versus calculated average particle radius in nanometers. Once
sufficient homogeneity of the samples was found for a particular condition, crystallization was
conducted for each of the purified protein samples.

2.2.5 – Crystallization Screening
Initial crystallization for each of the recombinant proteins was accomplished by the use of
sitting-drop vapour diffusion method. Each of the protein samples were concentrated further in a similar
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manner as described before to concentrations of 5-30mg/mL. Final concentrations for crystallization
were attempted at a range of 10-15mg/mL. For TDE0626, multiple trials for initial crystallization was
conducted at initial concentrations of 5, 8, 12, 15, 20, 25, 30mg/mL. For TDE1701, trials for
crystallization were conducted at an initial concentration of 20mg/mL. For TDE2714, trials for
crystallization were conducted at an initial concentration of 25mg/mL. Extinction coefficients for each of
the targets found in Table 3. For each of the concentrations the protein sample was centrifuged at
12,000xg at 4oC for 10 minutes in order to remove any aggregates found during the concentration step.
Crystal screening was set up using the Gryphon system with various crystal screens in 96-well
microplates. Crystal screens used were; the MCSG crystallization Suite for MCSG-1,2,3, and 4 crystal
screens, PACT PremierTM HT96 crystal screen, IndexTM HR2-144 crystal screen, and HR2-110 crystal
screen. The standard protocol set up for the sitting-drop vapour diffusion was a two-drop protein screen
with the ratio of reservoir to protein sample of 0.3µL:0.3µL as well as 0.3µL:0.2µL. The protein sample
(200µL) was placed in a 0.2mL tube for screening. An initial wash protocol used for the Gryphon prior to
the screening by the use of sterile filtered ultra-pure water which was run through the 96 syringe heads
and the protein needle. Once the initial wash was completed the sample was placed below the protein
needle where all 200µL of protein was aspirated into the needle. All 96 syringe heads drew 60µL of the
reservoir conditions for the crystal screens and a ratio of 3:3 or 3:2 of reservoir to protein was setup for
the sitting drops. Once completed, the microplate was sealed with a layer of HD Clear packaging tape
and incubated at 18oC. Crystal formation was monitored by the use of ZEISS SteREO microscope at a
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magnification of 1000X and the conditions which produced protein crystals were recorded and logged
for further optimization.

For the conditions which showed initial crystal formation, optimization was conducted using the
hanging-drop vapour diffusion technique at a larger sample volume. Conditions which produced crystals
were optimized by varying the concentration of the precipitating agents as well as the pH of the
conditions. The ratios used for the hanging protein drops were similar to initial crystallization at either
3µL:3µL or 3µL:2µL of the reservoir to protein sample. The conditions were replicated in TC Plate 24-well
cell culture plates and scaled to a reservoir volume of 500µL. The protein drops were placed on 18mm
siliconized glass cover slides which were cleaned in order to minimize dust particles. The rims of each of
the 24 wells were coated with vacuum grease in order to make a vapour tight seal. Once the conditions
and protein drops were set up, the whole plate was incubated at 18oC until crystal growth was
observed.

2.2.6 – X-Ray Diffraction Analysis and Model Building
Once large bulk crystals were formed, they were subjected to X-ray diffraction analysis in order
to build structural models of each of the targets. From both the initial sitting-drop vapour diffusion and
the 24-well plates were sent for diffraction. In order to do so, freezing of the crystals was conducted by
looping the crystals from the conditions and submerging them in a freshly made cryoprotectant. Each
cryoprotectant was tailored for each different condition as it contained all the same components as the
condition; however, also contained 30% (v/v) glycerol to prevent the formation of ice crystals. Once the
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crystals were submerged in the cryoprotectant, flash freezing using liquid nitrogen was used and the
crystals were subsequently stored in liquid nitrogen until shipped to the Canadian Light Source
Synchrotron (CLS) or the Advanced Photon Source Synchrotron (APS).

For X-ray diffraction analysis of each of the sent crystals, an initial test diffraction was conducted
at the angles of 0o, 45o, 90o. Each of the three images were examined for their diffraction quality in order
to determine the optimal angle to begin X-ray diffraction data collection. Once the images for both the
initial diffraction tests and the full datasets of diffraction were collected. iMOSFLM and SCALA were
utilized in order to determine crystallographic statistics from the images collected(77). The generation of
an electron density map was the was attempted after by obtaining phase information(78). This
information coupled with the homology modelling prediction was inputted into Phaser-MR for
molecular replacement and phasing. Once the models were generated, structural refinement was
conducted by both REFMAC-5 refinement software and experimenter input via COOT software. Several
rounds of refinement were conducted, and validation of the structural models produced were analyzed
for correctness via the molecular graphics software COOT(79).

2.2.7 – Selenomethionine Single-wavelength Anomalous Diffraction (SAD)
Selenomethionine derivative crystals for TDE2714 were also formed and utilized for diffraction
analysis. This was conducted by the growth of transformed BL21 E. coli cells in minimal media
(Molecular Dimensions) which contained 20mg/mL of L-selenomethionine from Bio Basic Inc. The small
10mL cultures were centrifuged at 12,000xg for five minutes before decanting the LB which contained
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methionine. Once the pellets were resuspended in ultra-pure water, the cells were centrifuged again at
12,000xg for five minutes and the water was decanted. The cell pellets were resuspended in the minimal
media which contained the L-selenomethionine and were grown in similar conditions to the native trials.
After cell lysis and subsequent purification, the concentrated selenomethionine containing protein
samples were initial screened via the sitting-drop vapour diffusion and optimized by the hanging drop
vapour diffusion. Large crystals were cryogenically frozen and sent to the CLS for anomalous dispersion
analysis. Using the anomalous signals from the selenium within the protein crystals, phase information
was attempted to be gathered from the data via Phaser-SAD.

2.2.8 – Site-Directed Mutagenesis of TDE2714
During the functional analysis of TDE2714, site-directed mutagenesis was employed in order to
generate a mutant that could be used for co-crystallization attempts with a peptide substrate. This was
conducted by miniprepping DH5α E. coli in order to obtain the tde2714-pET21b plasmid. A single primer
PCR reaction was conducted with either a forward or reverse primer containing a single point mutation
of the C637 codon from T to a G and G to a C. This mutation would cause for a change from a cysteine to
an alanine residue. The mutation was chosen based on the alignment of an active site cysteine from a
well-characterized FGE (PDB ID: 2AIK). PCR was conducted at using the 10µL of 5X Phusion HF buffer,
5µL of forward/reverse primer (100µM), 1µL of tde2714-pET21b (50ng/µL), 1µL of 100mM dNTP, 2µL of
DMSO (100%), 0.5µL of Phusion HF polymerase, and 30.5µL of nuclease-free water. The PCR reaction
was denatured 98oC for 30s and again at 98oC for 10s. The primers were then annealed using touchdown
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annealing at -0.4oC starting at 74.7oC. The primers were then extended at 72oC for 3.5 minutes. These
steps were repeated 25 times until a second extension at 72oC for 10 minutes. The completed PCR
reaction was then treated with 1µL of DpnI and incubated at 37oC for 1h. After this, 5µL of the reaction
was transformed into DH5α and BL21 E. coli for further plasmid production and expression. Samples of
the PCR product were sent for sequencing at Western University. The digested PCR sample was also
loaded on a 1%(w/v) agarose gel that contained 0.5 µg/mL of ethidium bromide and run at 100V for 1h,
prior to imaging.

2.2.9 – Functional Analysis for The Targets
Once the recombinant proteins were purified and shown to be homogeneous, various functional
analysis were conducted to evaluate each of the putative functions. This was based on the
bioinformatics predictions for each of the targets.

For TDE0626, the ability to degrade cellulose was test by incubating 5-50mg/mL of cellulose with
0.5mg/mL of TDE0626 for 1h at 37oC. The samples were the filtered through a 0.2µm filter before
loaded onto a 12% (w/v) acrylamide gel and run at 180V for 45 minutes. Once the electrophoresis
procedure was completed, the gel was treated with a silver nitrate solution for 10 minutes to develop an
image. An experiment was also designed to test the degradation of polysaccharides present in a red
complex biofilm. In order to do so, purified TDE0626 was subjected to crude biofilm isolates that were
tested for degradation. Concentration of biofilm were tested were at 25-500ng/mL at an incubation
temperature of 37oC for 1-3 hours. These reaction samples were at a volume of 20µL in order to allow
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for the loading of the samples onto a 12% (w/v) acrylamide gel which was run at 180V for 45 minutes.
Once the gel was finished running, the gel was treated with a silver nitrate solution for 10 minutes to
develop an image of the proteins and carbohydrates present in the biofilm. Each of the reactions were
run in triplicates and incubated at 37oC. Functional analysis of TDE1701 has not been investigated to
date.

For TDE2714, carbohydrate polyacrylamide gel electrophoresis (C-PAGE) was conducted by
incubating the purified protein with polysaccharides such as polygalacturonic acid. Purified TDE2714
(5ng/mL) was incubated with 0.5% polygalacturonic acid for 2h at 37oC. The samples were loaded onto a
15%(w/v) acrylamide and 1% (v/v) bis-acrylamide gel with 10% sucrose and 5mg/mL phenol red. The gel
was run at 200V for 2h. Staining the gel was done by incubating the gel in 5mg/mL phenol red for 10
minutes then rinsed with water for 1h, prior to treatment with 0.4% silver nitrate. Staining in silver
nitrate was done for 10 minutes and rinsed with water before being developed with 0.6M sodium
carbonate and 0.08% (v/v) formaldehyde. Development was stopped by 5% (v/v) acetic acid.

For TDE2714, a >95% purity synthetic peptide was ordered from Bio Basic Inc. with the sequence
LCTPSRA (sulfatase motif). The powered peptide was dissolved in ultra-pure water to a final
concentration of 370.88mM, which was the stock peptide solution. In order to test the function of the
enzyme, peptide-based thin layer chromatography (TLC) was employed. The enzymatic reaction
consisted of 1mM of the LCTPSRA, 0.1mM purified TDE2714 (7.4mg/mL), 50mM sodium phosphate
buffer pH 8.0, and 2mM DTT. Sodium phosphate dibasic pH 8.0 was used instead of Tris-HCl pH 8.0 due
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to the amine binding properties of the stain used. The mobile phase (solvent) used was a 3:1:1 ratio of
1-butanol: glacial acetic acid: and water. The stain used was 1% ninhydrin in a 5:1 (v/v) ratio of pyridine
and glacial acetic acid. The reaction volume was set to 100µL in which all the components were added
and TDE2714 was added last in order to begin the reaction. Reactions were then incubated at 37oC for 116 hours before TLC analysis. A half sheet of the silica gel 60 aluminum TLC sheet was marked with a
starting line of 1cm at the bottom for sample application and heated for 10 minutes at 120oC to activate
the silica. Once cooled, the TLC plate was placed into a glass developing chamber with approximately
250mL of the solvent and allowed to run up the plate until 1cm from the top of the plate. The plate was
then removed and dried to prepare for the sample application. The reaction samples were concentrated
using the Centrivap instrument at 60oC until the volume of sample was 10µL. Each sample (3µL) was
then placed onto the TLC plate above the 1cm line and allowed to dry. Once the plate was fully dry, it
was placed into the glass chamber and the solvent was allowed to run up the plate until 1cm from the
top. The plate was removed and dried using a hairdryer prior to staining. The stain solution was poured
directly on the TLC plate until the stain cover the whole of the TLC. This was then placed into an oven
and heated at 100oC for 5 minutes to develop the stain. Once the stain was developed and image was
taken using the Molecular Imager® Versa Doc MP System. Intensity readings for each of the developed
spots were measured and graphed for the visualization of product formation.

In a similar manner, the formation of the potential product of the enzymatic reaction was
conducted for electron spray ionization mass spectrometry (ESI-MS). Reaction samples were set up with
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the same components as the TLC protocol. These were incubated for 16 hours before being purified by
filter centrifugation and sent to the ESI-MS/MS at the Advanced Analysis Centre at the University of
Guelph. The samples were frozen for shipment. Samples were analyzed, and their mass spectra
compared by Dr. Dyanne Brewer (University of Guelph) to properly sequence and verify any changes to
the substrate peptide.

In order to better understand the result from the ESI-MS/MS, liquid chromatography-tandem
mass spectrometry (LC-MS/MS) was conducted at the University of Guelph. The peptide samples were
reacted for 16 hours, purified, and sent for LC-MS/MS where the retention times of the substrate
standard and the reaction samples as well as the spectrums were analyzed by Dr. Dyanne Brewer. All
the data from both the ESI-MS/MS and LC-MS/MS were tabulated and graphed for comparison.
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3. Results
3.1 – Bioinformatics
3.1.1 – Genomic and Transcriptomic Analysis
In order to gain insight into the role of Treponema denticola as a contributor to the progression
of human chronic periodontitis, genomic analysis and transcriptomic analysis were conducted. Previous
work by Eric C. Reynolds showed a higher expression of genes in T. denticola when in a mature biofilm
relative to its planktonic state. The analysis was conducted via microarray and hybridization assays in
which the total RNA of the bacteria was isolated and measured for changes in the expression levels
during its presence in a biofilm, as well as in its planktonic state. This analysis suggested that 126 genes
had a fold increase in their expression by 1.5-fold or higher (the threshold considered upregulated),
leading to the postulation that these genes are involved in the adaptation from planktonic state to
biofilm state. Systems were identified to be upregulated in the biofilm such as toxin-antitoxin systems
and expression of virulence factors such as; transposases, cystalysin, and lipoproteins(75). Data analyzed
from this study revealed three genes that were shown to have a significant fold increase in expression;
TDE0626, TDE1701, and TDE2714. These were functionally classified as putative uncharacterized
proteins (Table 1). The identification of three genes which had their expression increased in a biofilm
state served as the basis for further analysis into their role in the pathogenicity of T. denticola.
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Table 1: Transcriptomic analysis of three selected genes from T. denticola, which had a fold expression
change of 1.5 or higher.
Gene ID
TDE0626

Fold Change (Log2)
1.26

Adjusted P Value
7.2x10-18

TDE1701

0.99

3.5x10-14

TDE2714

1.02

1.2x10-14

Uniprot Function
Putative Uncharacterized
Protein
Putative Uncharacterized
Protein
Putative Uncharacterized
Protein

The transcriptomic data collected suggested that genes may have importance for the bacterial
pathogenicity, based solely on the increase in gene expression. This was shown by the small P value that
gave strong evidence to the data being true against the regular expression of the genes. However, the
transcriptomic data did not reveal any biophysical characteristics, such as structural elements or
functional properties, and so each gene product was labeled as uncharacterized. The putative function
for the product of the gene Tde0626 was discovered using reverse transcription PCR (RT-PCR) to be a
putative lipoprotein based on the functional cloning using the generated cDNA library. These are known
to be associated with virulence, as they play a role in the inflammatory response of hosts that is known
to cause tissue damage and cell lysis(80). The data shown in the study allowed for the development of a
hypothesis that these genes may play an important role in the survival of the pathogen as well as its
prevalence in the maturation of the biofilm.

To gain more insight into the characteristics of these genes, further genomic analysis was
conducted by the use of database searching such as; the National Center for Biotechnology Information
(NCBI), as well as Kyoto Encyclopedia of Genes and Genomes (KEGG). NCBI
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(https://www.ncbi.nlm.nih.gov/) is a large database that includes information from various other
databases such as; GenBank, PubMed, and 37 other databases that give insight into genetic
characteristics of genes in a particular organism, as well as information about the potential function or
associated function of the gene products(81). The information that NCBI provided about the three genes
gave genetic context about where the genes were located in the genome and the predicted function of
the genes expressed surrounding the three genes. Although these surrounding genes may not have any
relevant associations to the function of each gene, it was important for initial analysis to gain context of
the location of the genes, as well as potentially any associated genes nearby (Figure 1).
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Figure 1: Genomic context of the Tde0626, Tde1701, and TDE2714 genes of Treponema denticola ATCC
35405. Genomic range represented by yellow bar with nucleotide position within the genome of T.
denticola. Each gene of interest highlighted in red and surrounding genes shown in blue. For Tde0626
(hypothetical protein), gene location at 658,230 - 659,744 base pair. For Tde1701 (hypothetical protein),
gene location at 1758280 - 1759407 base pair. For Tde2714 (hypothetical protein), gene location at
2770717 - 2772708 base pair. Data obtained from NCBI Reference Sequence (RefSeq) in the NCBI
database. A putative function was only predicted for TDE0626 operon as being involved in carbohydrate
metabolism.
For Tde0626, upstream of the gene product is a putative ABC transporter ATP binding protein
(Tde0625) and downstream is a co-chaperone protein GrpE. The presence of a chaperone protein may
be important for the functionality of TDE0626 as it may require additional aid in its folding to be
functional(82). For TDE1701, upstream of the gene product is a serine/threonine protein phosphatase
(Tde1698). However, directly adjacent to the TDE1701 upstream and downstream, the gene products
are classified only as hypothetical proteins and give no additional information that could lead to a
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prediction of the function of TDE1701. For TDE2714, downstream of the gene product is an RNA
methyltransferase (Tde2713) and upstream is a haloacid dehalogenase (HAD) family hydrolase
(Tde2716). The presence of both of these gene products in close proximality to each other has been
known to be associated with formylglycine residue containing enzymes, as well as formylglycine
generating enzymes themselves in the biosynthesis of ergothioneine, which is a thiourea derivative of
histidine(83). The potential for each of the targets to be in an operon was investigated using the
Database of Prokaryotic Operons (DOOR2). For each of the targets, a search of the predicted operons in
T. denticola was conducted that was then complied into a table for all the genes predicted in the operon
as well as the confidence score for the prediction (Table A3 in Appendix). From the database, only
TDE0626 and TDE1701 were predicted to be part of an operon, where TDE0626 was a part of a 4 gene
operon involved in biosynthesis of precorrin-6x and vitamin B12. TDE1701 was identified to be part of a
2 gene operon of unknown function with TDE1700, a hypothetical protein.

Further genomic analysis was conducted via the use of KEGG (https://www.genome.jp/kegg/),
which is a collection of databases that aim to give insight into the higher level gene functions as well as
cellular systems, such as metabolism and signal transduction pathways(84). Each of the genes were
searched in KEGG to identify any known similarities to gene functions in bacterial systems. However, the
data was inconclusive about their involvement in known systems as they are classified as hypothetical
proteins and so other aspects of KEGG were utilized. The KEGG database also contained information
about predicted orthologs and paralogs for each of the gene products that could potentially give
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information about their putative function based on homologous proteins. Identifying orthologs each
gene product can reveal similar functions of proteins over a wide range of species and can aid in the
identification of the function of the uncharacterized protein, whereas paralogs can reveal new functions
of a class of proteins within an organism and is useful for discovering multiple homologous proteins in
an organism(85).

Table 2: Summary of predicted ortholog and paralog data from Kyoto Encyclopedia of Genes and
Genomes (KEGG) of each of the genes in study.
Gene
TDE0626

Number of Orthologs
1929

Number of Paralogs
0

TDE1701

3993

2

TDE2714

2113

16

Domain(s)/function
Cthe_2159
Carbohydrate binding
domain
None
bacteriocin-type signal
sequence
FGE-Sulfatase
Sulfatase modifying
factor

From the data collected from KEGG (Table 2), each of the genes had a large amount of orthologs
which were identified, with TDE1701 having the highest numbers identified. In light of this, it would
have seemed that the function of each gene products could be predicted, however the volume of
different functions found in the orthologs made for difficultly to develop a conclusive function.
Searching for paralogs within T. denticola did not reveal a large number of paralogs, in which TDE0626
had no identified paralogs. More conclusive functional predictions of the gene products were found by
comparing the gene products to the identified paralogs. The KEGG database revealed that TDE1701 may
be similar to a bacteriocin-type signal sequence, that is known to be a toxic bacterial peptide that is toxic
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to closely related bacteria(86). An example of this is the expression of enterolysin A, a cell walldegrading bacteriocin, which is known to inhibit the growth of Lactobacilli(87). Based on the data
collected from KEGG, TDE2714 may be similar to a FGE-sulfatase modifying factor, that is known to
modify either an active site cystine or serine of a type 1 sulfatase into a formylglycine residue(88).
Functional predictions were generated by searches into the Pfam database that looks for similarities to
known protein motifs. This information was then utilized to generate putative domains and boundaries
that are associated to the function of the uncharacterized protein(89). Using the information from this
database allowed for the hypothesis that a Cthe_2159 carbohydrate binding domain may be present in
TDE0626. The Cthe_2159 domain was identified from Clostridium thermocellum as a beta-helix
containing domain that binds to either cellulose or uronic acid containing sugars, such as cellulose,
xylan, or other glycosaminoglycans, and the domain shares similarities with the polysaccharide lyase (PL)
protein families(90). The similarities of the Cthe_2159 domain to TDE0626 suggests that either TDE0626
can bind to cellulose or to GAGs. Based on the genomic analysis, each of gene products may play some
role in the pathogenicity of T. denticola, either by aiding in the nutrition of the organism to its survival or
proliferation within a host.

3.1.2 – Predicted Biophysical Properties
Further analysis of the three gene products was conducted via the analysis of their primary
protein sequences. This was accomplished initially by the use of a program Protparam from the ExPASy
Bioinformatics Research Portal (https://web.expasy.org/protparam/). The software uses computational
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algorithms to analyze a protein sequence and predict the physiochemical properties. These properties
are based on the structural and functional characteristics of the hypothetical protein, however there is
no information given about the putative function or structural elements, only the parameters such as
the composition of the sequence and the molar absorptivity(91). Each of the primary sequences were
analyzed and the data was tabulated for comparison (Table 3).

Table 3: Predicted biophysical properties of gene subsequent primary sequences generated via
Protparam software from ExPASy Bioinformatics Research Portal.
Gene

TDE0626
TDE1701
TDE2714

Start – End
(amino acid
position)
25 - 479
1 - 375
1 - 663

Molecular
Weight (Da)
50058
39841
73955

Extinction
Coefficient (M1
cm-1) at 280nm
16390
30620
170225

Predicted
Isoelectric
Point (pI)
4.98
4.60
5.31

Number of
Methionines
10
6
7

TDE2714 had the highest molecular weight in comparison to the other proteins and had a
theoretical extinction coefficient of 170225 M-1cm-1. This value was calculated by the number of
aromatic residues at 280nm and may not represent the true extinction coefficient of the proteins. The
predicted isoelectric point (pI) was also calculated which is the point at which a certain pH value has a
neutral protein net charge(92). The pI was the lowest for TDE1701 at pH 4.06 and highest at pH 5.31 for
TDE2714. This value is important for further experimental analysis and development, as it allows for the
net protein charge to be changed from positive, neutral, and to negative, depending on buffering
conditions, which can be useful in a variety of applications. One such application could be to advance
crystallization of the expressed and purified protein, where acidic proteins tended to crystalize at a pH
just above their pI value, whereas basic proteins tended to crystallize at a pH below their pI(93). Another
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parameter which was important to note was the number of methionine residues per 100 amino acids
within each of the primary sequences. The number of methionine residues may play an important role
in the structural analysis of each of the recombinant proteins, as they may be replaced to the selenium
derivative methionine (selenomethionine) for anomalous diffraction experiments (SAD/MAD), which is
used for the determination of phasing during X-ray diffraction analysis(94). Based on the data, TDE1701
had the lowest number of methionine residues and TDE0626 had the highest methionine residues.

Protein localization or its subcellular localization can be useful information in bacteria as
knowing this information can aid in the understanding of the protein and its role in the organism as a
whole. Studies of subcellular localization of proteins in Gram-negative bacteria revealed that there are
five main localization sites; cytoplasm, periplasm, inner membrane, outer membrane, and
extracellular(95). In order to identify the localization of the proteins in T. denticola, various prediction
software programs were used that was condensed into searchable online database called Oralgen
(http://www.oralgen.org/cellular_location/) for the outputs of key localization software programs(96).
The programs which were found the database were Cello (cello.life.nctu.edu.tw/), SubLoc
(https://omictools.com/subloc-tool), subCELL (bioinformatics.ysu.edu/tools/subcell.html), PSORT
(https://www.psort.org/), and SignalP (www.cbs.dtu.dk/services/SignalP/)(97). Each of these programs
used a similar package of algorithms and input information which examined the query protein primary
sequences for characteristics such as composition of amino acids, presence of a signal peptide, similarity
to known protein localization, motifs similar to known localization, and the presence of transmembrane
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alpha-helices(95). From each of the programs used, all of the proteins were predicted to be
extracellularly localized, in that SignalP could only identify a signal peptide for extracellular localization
in TDE0626 and not the other two protein sequences. However, PSORT, which is one of the most widely
used localization tools(95), suggested that all of the protein sequences had motifs that were similar to
extracellular protein P-values. All three of the proteins are secreted from the organism into the
extracellular space, based on the localization tools. Studies have shown that the extracellular polymeric
substances that make up the matrix may contain a host of enzymes secreted from the bacteria in order
to aid in the formation and maturation of the biofilm(98).

3.1.3 – Protein Structure and Function Predictions
In order to identify the role of the upregulated gene products in T. denticola, additional
information about similarities to known protein structures and functions was generated. For each of the
proteins studied, their primary sequences were examined through software programs that searched for
main signatures from known protein structures; domain searching, homology modelling and motif
identification, known protein-protein interactions, and conserved regions of structural and functional
elements via multiple sequence alignments. To gain insight into the predicted domains or regions in
each of the proteins, their sequences were submitted to UniprotKB. This is a database that the
sequences were examined and evaluated against submitted scientific literature, as well as
computational analysis. The database was able to group each of the sequences to ones with similar
features in order to then identify regions of dissimilarity and generate domain parameters (Table 4)(99).
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Similarly, the InterPro database was used, that contained a protein signature recognition method that
was cross-linked with Uniprot to aid in the prediction of protein domains and putative functions.
InterPro uses Hidden Markov Models (HHMs), which is a statistical model that assumes that the system
analyzed is a Markov Model but has unobserved states(100). Using these two databases and processes,
additional information about the biophysical characteristics of the proteins were identified. The domain
predictions and feature positions shown (Table 4) were based on the FASTA sequence files from codon
optimized custom genes (Figure A6 in Appendix) as well as the length of the predicted regions.

Table 4: Domain and structural feature predictions using InterPro and UniprotKB databases for the
proteins; TDE0626, TDE1701, TDE2714.
Gene
TDE0626
TDE1701
TDE2714

Domain/features
Signal peptide
Cthe_2159
No domain prediction
FGE-Sulfatase

Position(s)
1-24
81-327
N/A
424-658

Length (amino acids)
24
246
N/A
235

Once the domain parameters were established using both databases, the data was tabulated for
the identification of predicted domains and putative functions(99). The information gathered revealed
similar results to the PSORT predictions and KEGG ortholog and paralog predictions. The data showed
that TDE0626 contained a signal peptide that was 24 amino acids long as well as a large Cthe_2159
carbohydrate binding domain, which is homologous to the polysaccharide lyase from C. thermocellum.
Unfortunately, the domain searching for TDE1701 was inconclusive and both were not able to identify
and any protein signatures or domains. For TDE2714, contained a large FGE-Sulfatase modifying factor
domain of 235 amino acids long. The other large region of the protein may be either structurally or have
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no inherent importance in the overall structure; however, further analysis was conducted to develop
more conclusive results.

Another method of analysis for the prediction of the structure and function of the proteins was
the use of StringDB database, which used the submitted primary sequences of the proteins to generate
predictions of protein-protein interactions and networks within the identified organism. This was then
able to suggest information about potential function and cellular systems(101). The database and
program worked by analyzing the sequence against scientific texts and genomic features from other
databases. This information was then used to generate interaction between orthologs as proteinprotein interactions (Table 5)(102). String analysis suggested the following information; similar genomic
context (neighborhood), proteins which are expressed together that have similar functions or
occurrence in metabolism (cooccurrence), association of genes based on predicted patterns known to
be in organisms (coexpression)(101)(103).
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Table 5: Summary of StringDB data showing only highest scored results for each of the three genes;
TDE0626, TDE1701, and TDE2714. Protein-protein interactions generated by similar features found
within orthologs.
Gene
TDE0626

TDE1701

TDE2714

Functional partner(s)
- TDE0625
ABC transporter ATPbinding protein
- TDE0658
ABC transporter permease
- TDE1698
Serine/threonine protein
phosphatase
- TDE1697 (gpmA)
Phosphoglyceromutase
- TDE2283
Permease
- TDE2410
Hemolysin

Neighborhood Cooccurrence Coexpression Score
- Yes
- No
- No
0.651

- No

-Yes

- No

0.437

- Yes

- No

- No

0.591

- Yes

- No

- No

0.447

- Yes

- No

-Yes

0.573

- Yes

-No

-No

0.550

Although the data may not suggest a similar trend as predicted by the prior bioinformatics tools,
the putative associations with known protein structures were shown. This may suggest that the proteins
being investigated share similar expression systems or are involved in similar cellular pathways within T.
denticola. The calculated score for each of the proteins is a confidence-based system. Based on the data,
TDE0626 shares similar genomic context with an ABC transporter ATP-binding protein that genetically is
located directly upstream from the gene, but did not show as co-expressed. StringDB also was predicted
for TDE0626 to have either similar function as to an ABC transporter permease or occur in the same
metabolic pathway; however, it does not share similar genomic context. The analysis suggested for
TDE1701 that it shared genomic context with both a serine/threonine protein phosphatase and a
phosphoglyceromutase. This meant that they are within similar regions of the genome and may not
have similar features to each other. TDE2714 has a similar genomic context to a hemolysin, as well as a
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permease. However, the database predicted that TDE2714 contained similar patterns in its primary
sequence that were associated with a permease. Based on this, TDE2714 may require a permease to
transport a specific molecule.

For further structural and functional analysis, homology modelling of each of the proteins was
conducted using various software packages. Protein Homology/Analogy Recognition Engine 2 (Phyre2)
was used, that is a fold recognition server that can generate predicted three-dimensional protein
structures via analysis of the submitted protein sequences. This software uses Hidden Markov Models
similar to InterPro and other algorithms against known protein structures and folds(104). These protein
structures were used as templates that can be used for intensive sequence alignments. In addition,
Markov models can predict potential mutation-sensitive positions in a submitted sequence in
comparison to known mutations in aligned sequences, which can suggest important catalytic segments
and regions(105). The primary sequences of the proteins were submitted to an intensive Phyre2 analysis
and the data which gave the best results were tabulated (Table 6).
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Table 6: Data generated from intensive homology modelling via Phyre2 software for the genes; TDE0626,
TDE1701, and TDE2714.
Gene

Template
Model
4phbA

Sequence
identity
(%)
34

Confidence Alignment
(%)
Coverage
(position)
98.8
65-293

TDE0626

TDE1701

5j73A

15

76.8

250-296

TDE2714

2y3cA
2q17C

45
29

100
100

394-660
402-659

1z70X

30

100

402-659

Template Information

Polysaccharide lyase-like
protein cthe_2159 from C.
thermocellum
De novo design of protein
homo-oligomers
- T. denticola variable
protein
- Formylglycine generating
enzyme from S. coelicolor
- C-type lectin-like,
sulfatase modifying factorlike protein

Only highest percent sequence identity models and confidence shown in the table. The fold
recognition software had similar results to the previous prediction tools for the protein TDE0626, that
contained similar signatures with the carbohydrate-binding domain from C. thermocellum and was
shown to have a 34% sequence identity at a 98.8% alignment confidence. The protein TDE0626 may
contain the predicted carbohydrate domain based on the presence of a similar beta-helix motif that may
bind polysaccharides. A low sequence identity and low sequence alignment confidence was shown for
TDE1701 that was similar to a de novo protein that was designed to be a bundle of homo-oligomers. The
coverage for the sequences and their alignment was small and suggests that only a small part of the
protein may be homologous. The software also predicted that TDE1701 was 50% intrinsically disordered
and therefore may be difficult to characterize further. For TDE2714, there were three high percent
identity models in which the highest was a characterized Treponema denticola variable protein with 45%
sequence identity. All the models had an alignment confidence of 100% which seemed suspect. In
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further studying the variable protein for its function, the protein PDB:2y3c, which is known to contain a
calcium-dependent lectin fold (C-type lectin). This is known to bind carbohydrates but also is involved in
the anticipatory ligand binding for immune response in vertebrates(106). The PDB:2y3c enzyme may be
similar to phage diversity-generating retroelements (DGRs) which are used by the pathogen to evade
the host immune system, via sequence variability(106)(Figure 2). The homology modelling seemed to
reinforce the prediction of a C-type lectin-like, sulfatase modifying factor-like protein with a 30%
identity. This prediction also contained similar alignment with the Formylglycine generating enzyme
(FGE) from Streptomyces coelicolor at 29% sequence identity (Figure 2). From the data for TDE2714 it
was inconclusive without further experimental analysis to determine if the enzyme was a lectin or an
FGE.

52

A

B

Figure 2: Protein models generated based on homology modelling software, Phyre² for hits with highest
sequence identity. Images generated via Pymol with a reduced solvent layer and primary sequence
shown. (A) Formylglycine-generating enzyme from S. coelicolor (PDB ID: 2q17) which showed a 29%
sequence identity to TDE2714. Catalytic cysteine residues 272 and 277 shown in yellow for 2q17. (B)
Putative formylglycine-generating enzyme, TDE2714 model based on sequence homology of 2y3c, which
showed a 45% sequence identity to TDE2714. Predicted catalytic cysteine residues shown in yellow and
alternative catalytic serine shown in red. The blue and purple colors are the peptide backbone colors
used from Pymol.
The modelling of TDE2714 onto 2y3c and 2q17 allowed for the identification of the position of
two putative catalytic cysteines for TDE2714 which may be able to bind to a cysteine residue on an
unfolded sulfatase enzyme to generate an active site formylglycine generating enzyme. This data was
gathered from previous work accomplished on the formylglycine-generating enzyme from S. coelicolor
which showed two catalytic residues in the active site(107).

Further structural and functional analysis was conducted via the generation of multiple
sequence alignments from homologous primary protein sequences from all domains of life. This was
accomplished by Protein Basic Local Alignment Search Tool (BLASTp) database coupled with Constraintbased Multiple Alignment Tool (COBALT). BLAST is a program that compares the query primary
sequence with other sequences to find similarities that can be used for seeding analysis of sequences.
This analysis then uses an algorithm to breaks up the sequence into short fragments, called ‘words’, and
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finds all possible combinations of the fragments and aligns them to gain a sequence similarity
score(108). The sequences were aligned with homologous sequences excluding the Treponema taxid, in
order to obtain a wider and more diverse alignment. TDE2714 aligned mostly with FGEs compared to all
other enzyme classes. The program COBALT was then able to align the sequences for further conserved
region mapping. ConSurf was used to generate conserved score for each of the amino acids in each of
the proteins studied based on the generated alignments. This was mapped onto the primary sequence
for the identification of conserved regions that may have putative structural and functional information.
The results (Figure 3) for TDE2714 had a highly conserved region (termed RLP region), that is also
conserved among all FGEs from both Eukaryotes and Prokaryotes, at the position at 531-539. Only one
highly conserved cysteine (Cys-625) was discovered and predicted to be functionally important.
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Figure 3: Conserved mapping of multiple sequence alignment from COBALT of TDE2714 primary protein
sequence. Conserved mapping was generated by ConSurf which was used to show regions of high
conservation from a scale of 1-9, where 9 is highly conserved among all FGEs. A large conserved region,
RLPTQAEWE, was found in the predicted FGE-sulfatase modifying factor domain. Predicted functional
elements label with a red f and structural elements labelled with a blue s.
Similar analysis via conserved mapping was conducted for TDE0626 and TDE1701 (Figures 21
and 22 in Appendix). For TDE0626, there is a highly conserved region at positions 369-375, that is
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predicted to be functional in a beta-elimination reaction with polysaccharides (DGIDSNG); however,
further experimental testing of this region being the functional domain has yet to be conducted. The
conserved mapping data for TDE1701 had a relatively low sequence conservation and one region of
average conservation at positions 103-108 (DNGDDE), that was predicted to be the important functional
region for the protein. However, no known domains or homologous proteins had been identified to
have this functional region and so further analysis will need to be conducted to determine the likelihood
of the conserved region being the functional region. It may be that this region is not the functional
region but may play a role in structural integrity of TDE1701.

3.2 – Protein Expression and Purification
3.2.1 – Bacterial Transformation and Recombinant Expression
The first objective was to successfully transform the genes of TDE0626, TDE1701, and TDE2714
into E. coli for recombinant expression. In order to do so, the genes housed in pET21b ampicillinresistant vectors, were transformed into a DH5α E. coli strain to maximize transformation efficiency and
harvest more plasmid. The increased uptake of plasmid is caused by the recA1 and endA1 mutations
that aids in insertion of the plasmids into the E. coli(109). Using the Qiagen Miniprep kit, the
concentration of isolated plasmid DNA for each of the genes was 28.8ng/µL of TDE0626-pET21b,
46.5ng/µL of TDE1701-pET21b, and 70.6ng/µL of TDE2714-pET21b. The concentrations were assessed
by measuring the 260nm absorbance for the isolated plasmid samples. Transformation into BL21 E. coli
cells allowed for the expression of each of the genes via the induction of the lac operon system in the
pET21b plasmids. This was accomplished via the use of a chemical compound called β-D-156

thiogalactopyranoside (IPTG) that is chemically similar to lactose at concentrations of 1mM IPTG
compared to 14mM of lactose(110). This compound was bound to the lac repressor during induction
and allowed for the T7 RNA polymerase to transcribe the three genes for recombinant expression(111).

3.2.2 – Initial Purification via Nickel NTA-IMAC
After centrifugation of 2L cultures of BL21 (DE3) cells, the recombinant proteins were harvested
via osmotic shock chemical lysis with a high sucrose concentration solution. This was accomplished due
to the change in osmotic pressure as the high amount of sucrose is added to the bacterial cultures
allowing for the water to flow into the cells and cause lysis of the cells. All of the lysis and resuspension
of isolated proteins were accomplished using a buffering solution of 50mM Tris-HCl pH 8.0 with 300mM
NaCl. Initially, TDE0626 expressing cells were treated in such a manner. However, upon further
purification steps it was shown that the use of chemical lysis with a buffering solution of Tris-HCl would
lead to the protein being lost to the insoluble portion of the lysate (Figure 4A). A different isolation
method was adopted for the extraction of TDE0626 by the use of ultrasonic frequency sonication of the
resuspended cell pellets containing the desired protein. The cells were resuspended as well in a
buffering solution of 100mM sodium phosphate at pH 8.0 in an attempt to resolubilize any of the
insoluble fraction, that contained TDE0626. The sonication method was used to disrupt the cellular
membrane which can also be called soniporation and did not require the use of a detergent to solubilize
the membrane after lysis(112). Cell lysis was achieved on at 4oC for 10 pulses of 20s, interspersed by 30s
rest periods to prevent temperature elevation. In comparison to chemical lysis of TDE0626, the results
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from the ultrasonic sonication revealed a large amount of protein within the buffered solution after the
initial purification step of immobilized nickel affinity chromatography (IMAC) (Figure 4B). The results
suggested that the dual change to sonication and a buffer of sodium phosphate allowed for the
increased solubility of TDE0626, which was able then to be further analyzed in a similar manner to the
other two recombinant proteins.

For the initial purification from the crude cell lysate, immobilized nickel affinity chromatography
was employed for each of the protein isolates. This was accomplished by the coordination of sixhistidine tags (six-His tag) on the recombinant proteins that bound to the nickel ions in IMAC (113). Each
of the bound protein samples were also washed with a buffering solution of either Tris-HCl or sodium
phosphate containing 5mM of imidazole and collected as wash solution. The wash was used to release
any weakly bound proteins or contaminants while the desired protein was coordinating to the nickel
resin. An increasing gradient of imidazole from 5mM-500mM in a similarly buffered solution was added
to the nickel resin in order to elute the bound protein from the resin. Fractions were analyzed by 12%
w/v SDS-PAGE (Figures 4 and 5).
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Figure 4: 12% (w/v) SDS-PAGE gels of TDE0626 after nickel-NTA IMAC purification. Lane 1 containing the
Precision Plus Protein™ Kaleidoscope ladder for each image. Both wash buffers for lysis method
containing 5mM imidazole and 300mM NaCl. The insoluble pellet and flow-through of each method was
collected and placed in lanes 2 and 3 of gels. An increasing gradient of imidazole (lanes 4-15) was
collected at; 5, 25, 50, 75, 100, 125, 150, 175, 200, 225, 250, 500mM. (A) Purification of TDE0626 via
osmotic shock chemical lysis in 50mM Tris-HCl pH 8.0 in 300mM NaCl. No bands visible after flowthrough of crude lysate. (B) Purification of via ultrasonic sonication in 100mM sodium phosphate pH 8.0
in 300mM NaCl. Large protein band at ~50kDa was observed above 75mM imidazole.
Likewise, both TDE1701 and TDE2714 were purified initially via nickel-NTA IMAC. However, they
did not require ultrasonication for cell lysis as the use of osmotic shock chemical lysis was sufficient in
maintaining the solubility of the isolated protein with relatively low amounts of inclusion bodies. This
was revealed during the purification as both proteins showed a large amount of protein within the
imidazole gradient during elution (Figure 5). The buffering solution of 50mM Tris-HCl (pH 8.0) with
300mM imidazole was used for the 5mM imidazole wash solution as well as the solutions for the
increasing gradient of imidazole.
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Figure 5: 12% (w/v) SDS-PAGE gels of TDE1701 and TDE2714 after nickel-NTA IMAC purification. Lane 1
containing the Precision Plus Protein™ Kaleidoscope ladder for each image. Both wash buffers for lysis
method containing 50mM Tris-HCl pH 8.0 with 5mM imidazole and 300mM NaCl. The insoluble pellet
and flow-through of each method was collected and placed in lanes 2 and 3 of gels. An increasing
gradient of imidazole (lanes 4-15) was collected at; 5, 25, 50, 75, 100, 125, 150, 175, 200, 225, 250,
500mM. (A) Purification of TDE1701 via osmotic shock chemical lysis in 50mM Tris-HCl pH 8.0 in 300mM
NaCl. A large band (~39kDa) began to show at 100mM imidazole. (B) Purification of TDE2714 via osmotic
shock chemical lysis in 50mM Tris-HCl pH 8.0 in 300mM NaCl. A large band (~75kDa) was observed to
show at 75mM imidazole.

3.2.3 – Dialysis and Secondary Purification
From the SDS-PAGE analysis, it was important to perform secondary purification to remove
contaminants present in the samples containing purified recombinant protein. A common method for
secondary purification is the use of ion exchange chromatography. The principle is that when the
purified protein is in a buffered solution at a pH different from its pI, it exhibits a net charge that can
then bind to an opposing charged resin. The bulk of the targeted protein is bound to the resin while the
contaminants are repelled or eluted during chromatographic separation(114). For each of the
recombinant proteins, the biophysical results showed that all the pI values were below pH 6. Anion
exchange chromatography was used, where the resin used was positively charged. The buffering
solution used for each purified protein was at 50mM Tris-HCl pH 8.0 for TDE1701 and TDE2714;
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however, a 100mM glycine pH 9.6 buffer was used for TDE0626. The choice of buffer was obtained by
screening various common buffers (bis-tris methane (bis-tris), 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES), glycine, 2-(N-Morpholino)ethanesulfonic acid (MES), sodium
phosphate, as well as sodium acetate). These buffers screened during lysis and were analyzed by SDSPAGE. The choice 100mM glycine at pH 9.6 allowed for the net charge on the isolated proteins to be
negatively charged and able to bind to the resin.

However, in working at a pH of 8.0 or 9.6, there was imidazole and salt present in the elution
fractions from the nickel-NTA IMAC that was needed to be removed from the solution. Dialysis was used
for each of the purified protein solutions into an imidazole free and salt free buffer of either 50mM TrisHCl pH 8.0 or 100mM glycine pH 9.6. Dialysis was accomplished using a semipermeable membrane
(molecular cutoff of 6-8kDa) which allowed for the imidazole and NaCl to be slowly removed from the
purified protein(115). After a 16-18-hour dialysis into the initial anion exchange buffer, TDE0626 began
to show some precipitation that required centrifugation to remove the insoluble protein from the
solution. Both TDE1701 and TDE2714 did not show visible precipitation after dialysis for 16-18 hours and
so they were directly purified via anion exchange chromatography using the HiTrapTM Q FF anion
exchange column.

Secondary purification via anion exchange was performed similarly for all the freshly dialyzed
protein samples. Appropriately equilibrated columns were loaded with each protein for two full cycles
of their total volume. Columns were washed for 10 column volumes with either 50mM Tris-HCl pH 8.0
61

for TDE1701 and TDE2714, or 100mM glycine pH 9.6 for TDE0626. In order to elute the bound protein
out of the column, an increasing gradient of NaCl was added to the column using the same buffer which
was in the wash and equilibration step but with 1M NaCl included. The chromatogram visualized the
protein being eluted from the column and was monitored via a constant absorbance reading at 280nm.

Absorbance at 280nm

For the TDE2714 protein sample a large single peak was shown on the chromatogram (Figure 6).

Volume (mL)

Figure 6: Chromatograph of anion exchange chromatography from purified TDE2714 in 50mM Tris-HCl
pH 8.0. Protein sample volume added to the GE HiTrapTM Q FF 5mL column was 100mL based on an
initial volume of 50mL, for two full cycles over the column. Absorbance units (mAU) at 280nm and
Conductivity (mS/cm) were below a value of 2.0 prior to sample application. Flow rate set to 5 mL/min.
The alarm for the delta column pressure maxima was set to 0.5MPa and minimum at 0.0MPa. Wash
buffer used was 50mM Tris-HCl pH 8.0 and elution buffer, for salt gradient elution was 50mM Tris-HCl
pH 8.0 with 1M NaCl. Peak fractions were at fractions 13-31 (38mL), which corresponded to the NaCl
concentration of 357mM. Blue line represents absorbance reading at 280 and dark brown line
represents conductivity.
The data from the anion exchange chromatogram for TDE2714 showed a broad peak, at
656.7mAU or 0.6567AU, during the sample application stage that represented the protein that did not
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bind to the positive resin. There was a large amount of protein contaminants from the nickel-NTA
chromatography. The chromatogram had a large absorbance peak during the fractionation stage at
1214mAU or 1.214AU that spanned fractions 13-31 (38mL). This was found to be the purified TDE2714
based on the absorbance at 280nm. TDE2714 was successfully purified from the contaminants using the
secondary purification. During the elution stage of the chromatography, the total concentration of salt
in the peak was approximately 357mM NaCl. This was relatively close to the amount used during IMAC.

The anion exchange chromatogram for TDE0626 had a broad peak of contaminants during the
sample application stage with a peak absorbance at 41.02mAU (Figure 7).
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Figure 7: Chromatograph of anion exchange chromatography from purified TDE0626 in 100mM glycine
pH 9.6. Protein sample volume added to the GE HiTrapTM Q FF 5mL column was 250mL based on an
initial volume of 175mL, for two full cycles over the column. Absorbance units (mAU) at 280nm and
Conductivity (mS/cm) were below a value of 2.0 prior to sample application. Flow rate set to 5 mL/min.
The alarm for the delta column pressure maxima was set to 0.5MPa and minimum at 0.0MPa. Wash
buffer used was 100mM glycine pH 9.6 and elution buffer, for salt gradient elution was 100mM glycine
pH 9.6 with 1M NaCl. Peak fractions were at fractions 18-30 (26mL), which corresponded to the NaCl
concentration of 238mM. Blue line represents absorbance reading at 280 and dark brown line
represents conductivity.
There was also a small and broad peak during the elution stage which had a lower absorbance
reading than the sample application stage at 38mAU. There was also a large shoulder on the peak that
may correspond to another protein eluded from the column. There were more proteins not bound to
the column than the amount that did and or column separation. The results lead to the assumption that
the protein TDE0626 was not able to successfully bind to the column fully and protein was lost from the
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purification step. The total concentration of salt in the peak was 238mM NaCl, that was lower than the
amount used for the IMAC.

The results for the anion exchange chromatography for TDE1701 showed a similarly broad peak
during the sample application stage at an absorbance of 134.65mAU (Figure A4 in Appendix). There was
a large single peak observed during the elution stage at 290.01mAU which spanned fractions 15-32
(36mL). TDE1701 was successfully purified from the protein sample with a low number of contaminants
based on the chromatogram. The concentration of the salt in the peak fractions was 337mM that was
similar to the amount of salt during the IMAC.

3.2.4 – Dynamic Light Scattering
In order to optimize the potential for protein samples to crystallize, it was necessary for the
purified samples to contain a low amount of aggregates and contaminants. To analyze purified samples,
dynamic light scattering (DLS) was employed using the protein samples after anion exchange
chromatography in 384-well plates at a final volume of 40µL. The samples were initially concentrated to
5mg/mL, where this concentration was lower than the concentration used during the initial
crystallization trials. The samples were exposed to a monochromatic light source that is then scattered
by the random Brownian motion of the particles in the sample(116). Fluctuations in the scattering
intensity and the subsequent particle movement were time-dependent so were able to give information
about the sample such as the diffusion coefficient, the predicted average radii of the particles, as well as
the polydispersity of the sample(117). The polydispersity measurement (%Pd) was used to for the
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distribution of particles in the samples and is a dimensionless parameter that is calculated by the
instrument using the polydispersity index. A polydispersity of 20% or lower indicated a relatively
monodispersed sample and this was used as the standard for comparison for all the protein scattering
measurements(118). This measurement was conducted in an opaque microplate using a small portion of
the concentrated protein sample. The scattering profile was condensed into a series of images for each
of the protein samples and a plot of each sample and the predicted homogeneity was shown (Figures 8
and 9).

Figure 8: Dynamic light scattering plot for 5mg/mL TDE0626 in 100mM glycine pH 9.6 after anion
exchange chromatography. Analysis depicts scattering profile as a measurement of predicted % mass
versus the calculated average particle radius (nm). The mass distribution for the protein sample shown
as three distinct peaks. Each peak shown with corresponding; radius, percent polydispersity (%Pd),
predicted molecular weight based on radius, percent intensity, and percent mass. Twenty images were
taken of the scattering profile every 5 seconds and averaged.
For the scattering profile of TDE0626 after anion exchange (Figure 8), three distinct peaks
corresponded to a percent of the total mass of the sample. The most predominant peak (at 96.7% of
mass) had a predicted particle radius of 3.433nm and a polydispersity of 25.6%. TDE0626 samples were
relatively monodispersed as it had a low particle radius and low polydispersity, despite the results by the
anion exchange chromatography, the sample still contained scattering that may be characteristic of
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aggregates or other particles. The predicted molecular weight based on the scattering profile was
60kDa, that was similar to the results calculated by Protparam (50kDa). The sample seemed to contain a
few population masses that may correspond other particles or precipitated protein, however they only
accounted for 3.3% of the total sample mass.

Figure 9: Dynamic light scattering plot for 5mg/mL TDE2714 in 50mM Tris-HCl pH 8.0 after anion
exchange chromatography. Analysis depicts scattering profile as a measurement of predicted % mass
versus the calculated average particle radius (nm). The mass distribution for the protein sample shown
as three distinct peaks. Each peak shown with corresponding; radius, percent polydispersity (%Pd),
predicted molecular weight based on radius, percent intensity, and percent mass. Twenty images were
taken of the scattering profile every 5 seconds and averaged.

For the scattering profile of TDE2714 after anion exchange (Figure 9), the results showed two
distinct peaks which corresponded to a percent of the total mass of the sample. The most predominant
peak (at 99.8% of mass) had a predicted particle radius of 5.247nm and a polydispersity of 30.1%. This
analysis suggested that TDE2714 samples were relatively monodispersed, although it has a high
polydispersity is was also known to be a relatively large protein at ~75kDa. The protein sample had a
higher particle radius and high polydispersity, that may be due to the size of the protein itself, however
more likely the protein exists as a dimer at a concentration of 5mg/mL. The predicted molecular weight
based on the scattering profile was 163kDa. Further analysis into the possibility of TDE2714 forming a
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dimer in solution may be required as the calculated molecular weight was twice the predicted weight of
a monomer of TDE2714. The sample contained a small mass that may correspond to other particles or
precipitated protein, as the predicted molecular radius was over 10 million Daltons, however this only
accounted for 0.2% of the total sample mass and are likely aggregates.

The dynamic light scattering results for TDE1701 after secondary purification (Figure A3 in
Appendix), had two peaks that were not distinct from each other. The most predominant peak (at 99.2%
of mass) had a predicted particle radius of 3.113nm and a polydispersity of 29.9%. The protein sample
was relatively high polydispersity and may be due to the prediction that 50% of the protein could be
intrinsically disordered. The protein sample had a low particle radius and high polydispersity and may
also support the prediction of TDE1701 being intrinsically disordered. The predicted molecular weight
based on the scattering profile was 48kDa, that is very similar to the results calculated by Protparam and
the protein sample. The sample seemed to contain a small mass that may correspond with other
particles or precipitated protein, however, this peak was not distinct from the main peak and this mass
may be denatured protein, however this only accounted for 0.8% of the total sample mass. DLS
summary table (Table A1) of the three targets can be found in the Appendix.
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3.3 – Crystallization
3.3.1 – Initial Sitting Drop Crystallization
In order to attempt to obtain structural information about each of the recombinant proteins, Xray crystallography was conducted. This was accomplished by the attempt for initial formation of
protein crystals using sitting-drop batch crystallization. After secondary purification and dynamic light
scattering, each purified protein concentration was calculated using the theoretical extinction
coefficients from Protparam. For the initial crystallization attempts, TDE0626 was concentrated to
30mg/mL as well as 20mg/mL in 100mM glycine pH 9.6 that reduced the amount of aggregates for the
protein during purification. TDE1701 was concentrated to 20mg/mL in 50mM Tris-HCl pH 8.0 that did
not produce aggregates at this high concentration. Finally, TDE2714 was concentrated to 25mg/mL in
50mM Tris-HCl pH 8.0 and did not produce aggregates at this concentration. This was deduced for all
the proteins based on visual observation of incubated crystallization plates which had a large number of
conditions that did not have visible precipitation. The lack of precipitation in the conditions meant that
the protein was stable in these conditions and higher concentrations of the protein could be used to
promote crystallization.

Purified TDE2714 was initially crystallized using the Molecular Dimensions MCSG-2
Crystallization Screen via sitting-drop vapour diffusion at a reservoir to protein ratio of 1:1. A single
crystal formed in the condition C10, which contained 0.2M sodium nitrate, and 20% (w/v) polyethylene
glycol 3350 (Figure 10). The temperature for incubation was 18oC for approximately 1 month before
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crystallization was recognized. The final concentration of protein for crystallization was 25mg/mL in the
drop.

Figure 10: Crystal growth for purified TDE2714 at a final concentration of 25mg/mL in 50mM Tris-HCl pH
8.0. Crystallization occurred using the sitting-drop vapour diffusion technique incubated at a
temperature of 18oC for approximately one month. Small plate-like crystals (resembling small diamondlike shapes) were seen in the C10 condition of MCSG-2, which contained 0.2M sodium nitrate and 20%
(w/v) polyethylene glycol 3350. Approximate size of crystals was 100µm.
Based on the size and morphology of the crystals, it was determined that further optimization of
the crystal growth was required. This was due to the size of the plate protein crystal being
approximately 100µm which would be relatively small for the subsequent X-ray diffraction analysis. In
addition, the condition for crystallization did not have a buffer present, expect for the buffer in the
protein solution and so the pH of the commercial reservoir solution was taken and determined to be pH
of 8.0.

Initial crystallization of TDE1701 was also successful in two different conditions that produced
crystals. TDE1701 crystallized in condition E3 from MCSG-1 which contained 0.05M magnesium chloride,
0.1M HEPES: NaOH pH 7.5, and 30% (v/v) polyethylene glycol methyl ether 550 (Figure 11A). The ratio
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for reservoir to protein was 1:1 and plates were incubated at 18oC. The crystals formed in approximately
3 weeks after incubation.

A

B

300µm

Figure 11: Crystal growth for purified TDE1701 in two different conditions. Final concentration for both
conditions was 10mg/mL in 50mM Tris-HCl pH 8.0. Crystallization occurred using the sitting-drop vapour
diffusion technique incubated at a temperature of 18oC for approximately three weeks. (A) Small
overlapping crystals with one larger crystal were seen in the E3 condition of MCSG-1, which contained;
0.05M Magnesium Chloride, 0.1M HEPES: NaOH pH 7.5, and 30% (v/v) Polyethylene glycol methyl ether
550. Approximate size of the largest crystal was 150µm. (B) A large collection of crystals with multiple
large crystals attached was seen in the C10 condition of the PACT screen, which contained; 0.2M
magnesium chloride, 0.1M HEPES: NaOH pH 7.5, and 20% (w/v) polyethylene glycol 6000. Approximate
size of the largest crystal was 250µm.
Another condition for TDE1701 was found to produce protein crystals (Figure 11B). Crystalline
TDE1701 was grown in the C10 condition of PACT premier™ HT-96 from Molecular Dimensions. The
protein concentration, incubation period, and temperature were the same as previously repeated as
stated above. The C10 PACT condition contained 0.2M magnesium chloride, 0.1M HEPES: NaOH pH 7.5,
and 20% w/v polyethylene glycol 6000. TDE1701 crystallization requires the presence of a low
concentration of magnesium chloride, as well as a HEPES buffer at pH 7.5. Both conditions required
optimization in order to produce better quality crystals for X-ray diffraction analysis. The presence of
Mg2+ in the condition may also suggest this to be a cofactor for TDE1701.
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Unfortunately, attempts for the crystallization of TDE0626 were unsuccessful even at a variety
of concentrations. Concentrations of 5, 8, 12, 15, 20, 25, and 30mg/mL did not yield any crystals at a
ratio of 1:1 reservoir to protein. Buffers present in concentrated protein were 100mM glycine pH 9.6
and 100mM Na2PO4 pH 8.0. After anion exchange chromatography, the protein was further dialyzed to
remove all traces of salt. All available crystallization screens were used for the purified protein such as
MCSG1-4, PACT, Hampton Research Crystal Screen™ HR2-110, Index™ HR2-144, and Molecular
Dimensions Morpheus-HT-96. Each screen was incubated at 18oC until all conditions were shown to be
precipitated protein and no crystal growth.

3.3.2 – Optimization of Crystal Growth
Since the size and morphology of the initial protein crystals were not ideal for X-ray diffraction
analysis, the conditions were expanded by increasing the volume of protein used as well as reservoir
used. Instead of 0.6µL sitting drop to 60µL of the reservoir, a total of 500µL of reservoir solution would
be used and subsequently 6µL of the protein/reservoir drop was used. This larger volume was used in
order to generate large protein crystals by allowing for more protein to be packed into a crystalline
structure. Due to the size of the solutions used, a hanging drop vapour diffusion method was introduced
instead. This method has been known to produce more bulky crystals when conditions that produced
small crystals were used by this method(119). Based off the results for TDE1701 and TDE2714, the
crystal conditions were altered by increasing and decreasing the concentration of polyethylene glycol to
determine a more optimal percentage of the precipitating agent (120). Optimizing conditions for
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TDE2714 was conducted using the purified protein in Tris-HCl pH 8.0. Hanging drop vapour diffusion was
setup in a 24-well plate with concentrations of TDE2714 at 12, 14, and 16mg/mL. The concentration of
polyethylene glycol was adjusted from 19.6% to 20.2% (w/v). This was conducted based on the known
principle that PEGs, exert the volume-excluded effect (or increase in the viscosity) as well as they
decrease the dielectric constant of the solvent which allows for the electron densities to be similar to
water and not damaging(119,120). There was an addition of two organic solvents which were glycerol
(2.5% v/v) and ethylene glycol (5% v/v). These solvents were used to impact crystallization to prevent
the formation of a large number of microcrystals. Organic solvents also are used to remove water
localized areas and divert their interactions with the protein, which allowed for better crystal
formation(123). The pH of Tris-HCl ranged from 7-8 based on pH test of commercial reservoir solution.
Plates were incubated at 18oC for 1 month (Table A2 in Appendix). In addition, crystallization of TDE2714
was performed with 2mM cysteine as TDE2714 hypothesized to interact with cysteine.

From the data presented in the table A2, there were 8 separate conditions that yielded large
protein crystals for TDE2714. The results showed that the crystal growth was successfully optimized for
diffraction analysis due to the size and morphology of the protein crystals (Figure 12). These crystals
(Figure 12) were the best conditions thus far for TDE2714.
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Figure 12: Optimized crystal growth for purified TDE2714 in three different conditions. Final
concentration for protein conditions was; 12, 14, 16mg/mL in 50mM Tris-HCl pH 8.0. Crystallization
occurred using the hanging drop vapour diffusion technique incubated at a temperature of 18oC for
approximately one month. (A) A large 400µm protein crystal was formed from condition A1 of the plate,
which contained 2.5% (v/v) glycerol, 50mM Tris-HCl pH 7.0, 19.6% (w/v) PEG 3350, and 0.2M NaNO3. (B)
A large 300µm protein crystal was formed from condition C3 of the plate, which contained 2.5% (v/v)
glycerol, 50mM Tris-HCl pH 8, 20% (w/v) PEG 3350, and 0.2M NaNO3. (C) A large 600µm protein crystal
was formed from condition D5 of the plate, which contained 5% (v/v) ethylene glycol, 50mM Tris-HCl pH
8, 20.2% (w/v) PEG 3350, and 0.2M NaNO3. All stated protein sizes were approximated, and may not be
accurate, based on size of loop required for harvesting.

The changes to the polyethylene glycol concentration for the conditions allowed for the
increased size and three dimensionality of protein crystals for TDE2714. The morphology of the crystals
was bulky diamond shaped. There were also two organic solvents (glycerol and ethylene glycol) added
to the conditions which aided growth of the protein crystal. One observation during the incubation of
the plate was that the protein seemed to aggregate together and precipitate out initially. However, over
the course of approximately 1 month, some of the precipitate dissolved and crystals developed.

Based on the results for the optimization of TDE2714 crystal growth, TDE1701 crystallization
was also attempted be optimized in a similar manner. However, the hanging drop method did not seem
to produce protein crystals for TDE1701 at incubation temperatures ranging 4oC (to slow the motion
within the protein drop) up to 20oC. Changing the concentration of polyethylene glycol by increasing or
74

decreasing also did not allow for the formation of TDE1701 crystals. The use of hanging drop vapour
diffusion for TDE1701 was not ideal for crystal formation and so this was not further explored.

In a similar manner, no optimization of crystal growth was conducted for TDE0626 as initially
there were no crystals formed via sitting-drop vapour diffusion. Further crystallization attempts with a
range of additives, such as reducing agents, polyamines, volatile and non-volatile organic solvents, and
chaotropes, will be added to the protein sample prior to crystal screening. This additive technique has
been known to aid in the crystallization of difficult proteins(119,120).

For each of the protein crystals sent, a cryoprotectant was used during the looping process. This
was done in order to prevent the formation of ice crystals during the flash-freezing process in liquid
nitrogen(126). The buildup of ice crystals during the diffraction analysis produces large dark ice rings in
the pattern which decreased the ability for proper indexing of the data(127). A cryoprotectant
containing 30% (v/v) glycerol, 0.2M sodium nitrate, 20% (w/v) polyethylene glycol 3350, and 50mM TrisHCl pH 8.0, was used after each of the TDE2714 crystals were removed from the hanging-drop. Each of
the crystals showed no change in morphology when suspended in the cryoprotectant and therefore
were flash-frozen with liquid nitrogen for shipment to the CLS.

In a similar manner, the protein crystal from of TDE1701 was suspended in a cryoprotectant that
contained; 0.05M magnesium chloride, 0.1M HEPES: NaOH pH 7.5, and 30% v/v polyethylene glycol
methyl ether 550. No glycerol was added to the cryoprotectant as the presence of 30% v/v polyethylene
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glycol methyl ether 550 served as a sufficient cryoprotectant. Like-wise no changes to the size or
morphology were seen during the suspension of the crystals.

3.4 – X-Ray Diffraction Analysis
3.4.1- Diffraction Quality Crystals and Diffraction Pattern Analysis
For structural characterization of each of the recombinant proteins, TDE1701 and TDE2714,
large crystals were sent to the Canadian Light Source (CLS) Synchrotron for X-ray diffraction. During the
X-ray diffraction of the protein crystals for TDE1701, the X-ray wavelength used was 0.97949 Å at a slit
width of 0.5µm. Images were collected on oscillation-mode, set to 0.2o oscillations over a 720-degree
total rotation in which the 1800 images were indexed, merged and processed via a built-in Mx Live
processing program. The diffraction data key indicators were tabulated for quality analysis (Table 7).

Table 7: Crystallographic statistics for the best collection and refinement of TDE1701. Data collected at
the Canadian Light Source synchrotron at an X-ray wavelength of 0.97949 Å. 1800 images taken over a
720-degree rotation at 0.2o oscillations. Data shown was processed via SCALA. Molecular replacement
used Phaser-MR software and refinement software used was Refmac-5. Ramachandran statistics were
generated via COOT model building software.
Diffraction Collection
Space group
Cell dimensions
a (Å)
b (Å)
c (Å)
α (degrees)
β (degrees)
y (degrees)
Resolution (Å)
CC1/2
I/σI
Completeness (%)
Multiplicity
Average mosaicity

P212121
51.09
156.70
158.01
90.0
90.0
90.0
50.0-2.40 (2.53-2.40)
0.99 (0.823)
34.6 (2.2)
99.4 (100.0)
11.9 (12.4)
0.2
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The data from the diffraction collection of TDE1701 had an outer shell resolution truncated at
2.4 Å and an inner shell resolution of 50Å. This high-resolution measurement had 100% completeness of
the data in the highest resolution shell. There was an adequate number of reflections included in the
reciprocal space of the asymmetric unit for the calculated space group of P212121(128). However, from
the data processed by SCALA, the Rmerge value was 1.089 in the outer shell that meant there were
discrepancies of the reflections over multiple measurements in the in the data collected. The space
group of the protein crystal was orthorhombic, that has been known to be most frequently predicted
space group for protein crystals(129). Based on the data collected, the I/σI value, that in terms is the
signal to noise ratio at 2.2, suggesting the resolution range was suitable at this resolution. Additionally,
the CC1/2 indicator was 0.823 indicating that the there was an acceptable correlation of the observed
dataset to the unmeasurable true signal, based on a CC1/2 cutoff of 1.

Molecular replacement for TDE1701 was attempted in order to obtain phase information in
order to build a structural model of the protein. Phaser-MR was used with the input of homologous
protein PDB file 5j73A, that had a sequence identity of 15% at the amino acid level, but only had an
alignment coverage from positions 250-296 in the sequence. Using the coordinates from the PDB file
and the collected X-ray data, a protein model was generated and refined using Refmac-5 (Table 8).
Based on the data generated by model refinement, the data was a poor representation of the data
collected. Based on the high Rwork/Rfree values, the ‘model’ generated was a poor representation of the
true structure analyzed, as this ratio is a valid indication of model quality(130). Furthermore, a Matthew
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coefficient generated within CCP4 suggested the presence of two molecules in the asymmetric unit of
TDE1701 based on 53.5% solvent volume. An image of the model of TDE1701 was taken via COOT
however the data should not be interpreted as a correct structural model of TDE1701 (Figure 13).

Figure 13: Overall best output from molecular replacement and initial model refinement for TDE1701 via
COOT model building software. The generated model shown represented was more consistent with
random scattering of water molecules rather than prediction of the true structure based on the values
for Rwork/Rfree. Molecular replacement conducted via Phaser-MR and model refinement generated by
Refmac-5. Rwork/Rfree for model was 0.48/0.53. Blue contour of the electron density shown represents
the known crystallographic data at 1.57 Å signal cutoff.
In a similar manner, protein crystals of TDE2714 were diffracted for structural characterization.
The X-ray beamline used had a wavelength of 1.000Å and the crystal was imaged at 0.2o oscillations for
a total of 720o and the processed data was tabulated for analysis via SCALA (Table 8).
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Table 8: Crystallographic statistics for the best collection and refinement of TDE2714. Data collected at
the Canadian Light Source synchrotron at an X-ray wavelength of 1.0000. Images taken at 0.2o
oscillations for a total of 720o rotation. Data shown was processed via SCALA. Molecular replacement
and Refinement (not included) did not yield sufficient data for model building.
Diffraction Collection
Space group
Cell dimensions
a (Å)
b (Å)
c (Å)
α (degrees)
β (degrees)
y (degrees)
Resolution (Å)
Rmerge
CC1/2
I/σI
Completeness (%)
Multiplicity
Average mosaicity

P21
100.02
102.13
113.34
90.00
109.34
90.00
48.41-2.75 (3.03-2.75)
0.159 (0.819)
0.99 (0.81)
8.4 (2.2)
99.9 (99.7)
7.5 (7.8)
0.4

The unmerged data set generated by the program SCALA, revealed a primitive monoclinic P21
space group that had a resolution of 2.75 Å in the outer shell and a 48.41 Å resolution in the inner shell.
At the resolution cutoff at 2.75 Å, the completeness was 99.7%. In addition to the completeness, the
signal to noise ratio was 2.2 in the highest shell. In contrast however, the Rmerge value was relatively high
for the dataset at 0.819 at the 2.75Å resolution. Phaser-MR was attempted to obtain phase information.
Based on the Matthew’s coefficient, three molecules were calculated within the asymmetric unit at a
cell volume of approximately 50.5% solvent. Molecular replacement was conducted using the
homologous protein model (PDB:2y3c) that was the Treponema denticola Variable Protein with an
amino acid sequence identity of 45% and aligned with positions 394-660 of TDE2714. However, the
phases generated via molecular replacement was insufficient to be able to generate a structural model.
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3.4.2 – Selenomethionine Crystallization
To attempt the experimental determination of phase information, crystallization of
selenomethionine crystals was conducted using the same optimized conditions for TDE2714. This
procedure was performed in order to obtain better quality phase information via the use of anomalous
diffraction experiments (SAD/MAD). The phase problem is defined as the lack of phase information of
the scattered X-rays which hit the detector after diffraction. This information is crucial as it is required to
calculate the electron density by breaking down the complex waves into simple waves via the Fourier
Transform(131). In order to overcome this challenge Selenomethionine containing crystals were
successfully grown (Figure 14). In anomalous dispersion experiments, selenium (as well as other heavy
metals) are exposed to wavelengths that are at the natural frequency of the metal ions. This causes for
an absorption of the wavelength and a breakdown of Friedel’s Law. This phenomenon can then be
identified as distinct atomic anomalous scattering signals, and once the position and amplitude of the
ions is identified, the phase can be calculated of the anomalous scatterer(132). The selenomethionine
crystals were flash-frozen in a similar cryoprotectant for the native TDE2714 crystals and sent to the CLS
for diffraction. The protein crystals were found to have a similar outer shell resolution of 2.71 Å. Three
fluorescent test scans were conducted for the TDE2714 crystal at selenium absorbance peak edge of
12665.7eV and an inflection peak of 12667.7eV (Table A4 in Appendix). Anomalous signals for selenium
ions were unable to be detected when scanned from. With the lack of anomalous signals, the data was
insufficient to aid in the generation of a protein model of TDE2714. For all three of the recombinant

80

proteins, it was apparent that further crystallization and diffraction analysis will be required in order to
obtain structural information.

500µm

Figure 14: Crystal growth for purified Selenomethionine containing TDE2714. Final concentration for the
protein conditions was 12mg/mL in 50mM Tris-HCl pH 8.0. Crystallization occurred using the hanging
drop vapour diffusion technique incubated at a temperature of 18oC for approximately one month. This
was similar to native conditions. (A) A large 300µm protein crystal was formed which contained; 2mM
cysteine, 2.5% (v/v) PEG 400, 0.2M NaNO3, 50mM Tris-HCl pH 8.0, 20% (w/v) PEG 3350. 2.5% (v/v) PEG
400 was added to condition to further increase in the viscosity of the condition.
3.5 – Functional Analysis
3.5.1 – Site-Directed Mutagenesis of TDE2714
Based on the conserved residue map of TDE2714 against 100 different FGEs, there were
residues in the sequence of TDE2714 that were found to be highly conserved across all the FGEs
analyzed. In determining a possible residue to change, a sequence comparison was conducted for
TDE2714 and a cysteine-active FGE from S. coelicolor (PDB: 2AIK) that has two catalytically active
cysteines in its active site. One of these cysteines from 2AIK aligned with cysteine-637 of TDE2714 and
this cysteine was chosen to be changed into an alanine via site-directed mutagenesis. After PCR was
conducted an agarose gel was run for the PCR samples (Figure A7 in Appendix). The target PCR product
of the gene was 1998bp and a prominent band can be visualized on the agarose gel at ~ 2kbp. This band
was extracted and sent to Western University for sequencing. The results of the sequencing were able to
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confirm a single amino acid change at position 637 from cysteine to alanine. The mutant was then
transformed into BL21 cells and successfully expressed and purified for analysis.

3.5.2 – TDE0626 as a Polysaccharide Lyase
Based on the information gathered by the bioinformatics of TDE0626, the putative
polysaccharide lyase function was further explored. The polysaccharide lyase was predicted to degrade
1-4-α or β uronic acids by a β-elimination reaction based on identified parallel β-helix motif that is
common to this family of enzymes(90,128). Based on the bioinformatics, TDE0626 may be involved in
nutrient uptake and/or dispersal of the biofilm(12). Initially, TDE0626 was test for its ability to degrade
cellulose by incubating purified TDE0626 with cellulose and imaged using silver nitrate (Figure A8 in
Appendix). Since TDE0626 was predicted to be a polysaccharide lyase that degrades GAGs, the enzyme
was unable to degrade cellulose based on the lack of bands visualized from the silver stained acrylamide
gel. The polysaccharide lyase activity was examined by the degradation of a biofilm extract from a coculture of the red complex that was developed and conducted by Vasu Patel. Isolated biofilm was
accomplished by Chris Bartlett and Sidney Nechacov. The biofilm degradation assay was conducted via
the addition of purified TDE0626 into the isolated biofilm with an incubation period of 1-3 hours at 37oC.
A silver-stained polyacrylamide gel was used for determination of biofilm degradation (Figure 15).
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Figure 15: SDS-PAGE gel imaged via silver staining of biofilm degradation for TDE0626. Purified TDE0626
was incubated with an isolated biofilm generated by the red complex bacteria; T. Forsythia, P. gingivalis,
and T. denticola. Treated biofilm samples were incubated for 1-3 hours at 37oC in order to ensure
complete degradation of the biofilm. Lane 1 contained the Precision Plus Protein™ Kaleidoscope ladder.
Lane 2 was 500ng/mL of TDE0626. Lane 3-8 were isolated biofilm prior to treatment at increasing
concentrations from 25-500ng. Lane 9 was TDE0626 supernatant collected after reactions. Lanes 10-15
were subsequent washes of TDE0626 with 1M NaCl samples.
The silver staining assay had an interesting banding pattern from the salt precipitated samples.
In lanes 10-15, there were visible bands that had a lower apparent molecular weight then the untreated
samples. This may have been caused by the degradation of GAGs found in the biofilm however, this may
also be caused by the degradation of the protein sample itself. that the biofilm was not successfully
degraded by TDE0626. This uncertainty was due to the use of a silver nitrate stain as it is an
indeterminate stain and will stain both carbohydrates and proteins, making for resolution of the two
molecules to be unattainable. A crystal violet assay to quantify the degradation of the biofilm by visual
tracking of the degradation was also none resultant(134). In spite of the uncertain results for the biofilm
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assay and the unsuccessful results of the crystal violet assay, TDE0626 may still be a polysaccharide
lyase, and may be able to successfully degrade the biofilm isolates. Further testing would be required.

3.5.3 – TDE2714 as a Formylglycine-Generating Enzyme
3.5.3.1 – Carbohydrate-PAGE of TDE2714
Initially the carbohydrate-binding function of TDE2714 was examined by carbohydrate-based
polyacrylamide gel electrophoresis (C-PAGE). For each of the experiment, TDE2714 was treated with
polysaccharides such as polygalacturonic acid, as the long chain carbohydrates may be similar in
structure to the natural substrate of TDE2714 in a biofilm. It was hypothesized that if TDE2714 was an
extracellular carbohydrate-binding protein, it would possibly bind to various polysaccharides or GAGs
found in the mature biofilm. Based on the C-PAGE results (Figure A9 in Appendix), there was no visible
change in the mobility of the TDE2714 in C-PAGE when treated with 0.5% (w/v) polygalacturonic acid.
The lack of change in the mobility of TDE2714 suggested that there was little to no interaction with the
long chain carbohydrate(135).

3.5.3.2 – Peptide Thin-Layer Chromatography of TDE2714
Important also for the nutrient uptake of bacteria is the scavenging of sulfur from sulfate
surface glycans(136). One of the main contributors to this has been sulfatases. Interestingly, based in
the bioinformatics, TDE2714 contains a FGE (formylglycine-generating enzyme) – sulfatase domain, that
is known to modify a cysteine or serine residue on a type I sulfatase via oxidation to a oxoalanine (or
formylglycine)(137). Since the Eukaryotic system for FGEs has been well characterized, a synthetic

84

peptide (-LCTPSRA-) of the sulfatase signature sequence was synthesized and reacted with purified
TDE2714(138). Initial results for the enzymatic reaction showed the formation of a noxious rotten eggs
smell that could indicative of the formation of hydrogen sulfide(139). Based on the purposed enzymatic
mechanism, the target cysteine on the peptide substrate could have been modified to a formylglycine
residue. The hemolytic properties of H2S have been extensively studied on tissue damage and can be
utilized for pathogens invading hosts for nutrient accessibility(71). As such, it was hypothesized that
TDE2714 may have some hemolytic activity within the host through this modification and subsequent
formation of H2S.

To further test this hypothesis, a thin-layer chromatography (TLC) protocol was develop with the
aid of Peter Nguyen (Dept. of Chemistry and Biochemistry, WLU) and amino acid/peptide TLC
protocols(140). Ninhydrin (1% (w/v)) was chosen as the developing stain for silica TLC plate and was
selective for the primary amine groups on the peptide used. When TDE2714 was in the presence of the
peptide substrate, there was a separate spot that migrated farther up the plate than samples without
the peptide substrate or enzyme itself. A new non-polar product was formed during the reaction that
may have been the oxoalanine residue, as the mobile phase used contained 60%(v/v) 1-butanol. A fulltime course reaction was conducted to identify a visual rate of the reaction and formation of product
(Figure 16).
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Figure 16: Time-course peptide thin-layer chromatography of TDE2714, a putative formylglycinegenerating enzyme. Each of the samples were composed of 0.1mM purified TDE2714 in 50mM sodium
phosphate pH 8.0, 1mM of LCTPSRA peptide substrate, and 2mM dithiothreitol (DTT). Samples were
incubated at 37oC for time periods of; 1, 2, 4, 8, and 16 hours. The stationary phase used was Millipore
TLC Silica gel 60 and the mobile phase was 3:1:1 of 1-butanol: glacial acetic acid: water. The experiment
was conducted in triplicates and developed via TLC stain of; 1% (w/v) ninhydrin in 5:1 (v/v) pyridine:
glacial acetic acid. Three spots for each of the reactions was observed were denoted as either the
enzyme, substrate, or product based on mobility on plate.

From the peptide TLC results, three distinct spots were visualized. The spots that were located
at the bottom the plate corresponded to the enzyme in the reaction based on prior testing in the
absence of the peptide substrate, where the enzyme alone lacked mobility on the plate. There was a
consistent concentration of enzyme added to each of the reactions (0.1mM). It was also observed that a
second less polar spot or smear was stained, this was assumed to be the unmodified peptide substrate
in each of the samples. This assumption based on prior testing with the peptide substrate in the absence
of the enzyme (Figure A10A in Appendix). There was also a third non-polar spot that appeared during
the second hour of the enzymatic reaction and increased in intensity over the course of time. The non86

polar product was possibly caused by the formation of the oxoalanine/formylglycine. In addition to the
formation of the potentially modified product, there was also a disappearance of the peptide substrate
over the time elapsed that may be caused by the substrate was being converted to the non-polar
product. In order to better visual the data, an image was taken, and the relative intensities could be
measured and plotted against the time elapsed (Figure 17).

38000
37000

Intensity (A.U.)

36000
35000
34000
33000
32000
31000

30000
29000
0

2

4

6

8

10

12

14

16

18

Time (hrs)

Figure 17: Relative intensity over time elapsed of the third most polar spot from the time course thinlayer chromatography of TDE2714 reaction. The TDE2714 reaction contained; 0.1mM purified TDE2714
in 50mM sodium phosphate pH 8.0, 1mM of LCTPSRA peptide substrate, and 2mM dithiothreitol (DTT)
and were incubated at 37oC for time periods of; 1, 2, 4, 8, and 16 hours prior to staining. Intensities were
measured via the VersaDoc densitometry function, where each spot’s intensity was measured with the
same cell volume. Each measurement was conducted in triplicates.
There was a measurable increasing in the intensity for the potential peptide product formation,
that reached a peak intensity of approximately 37000 A.U. at 8hrs before decreasing to 33000 A.U. The
data had similarities to a Michaelis-Menten saturation curve. This gave an indication that there was an
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enzymatic reaction that occurred and so further analysis via the characterization of the potentially
modified peptide product was conducted.

Using the C637A mutant in place of the wild-type TDE2714, a similar peptide TLC experiment
was conducted. This was used to determine if cysteine-637, which aligns with a known catalytic cysteine
in an FGE from S. coelicolor, is important for the function of TDE2714. The TLC experiment with the
C637A mutant was similar to the TLC experiment with the wild-type (Figure A10B in Appendix). The nonpolar spot that was assumed to be the modified peptide product was still visible suggesting that the
mutant of TDE2714 remained catalytically active. The retention of activity of the mutant suggests that
cysteine-637 is not catalytically integral for TDE2714.

3.5.3.3 – Electro-Spray Ionization Mass Spectrometry of Peptides
For the characterization of the putative product from the enzymatic reaction, electron spray
ionization mass spectrometry was conducted. Analysis of aqueous samples was done at the Advanced
Analysis Center at University of Guelph by Dr. Dyanne Brewer. Samples of the unmodified and 16h
(modified) reactions were flash-frozen and sent directly to the facility. This was done in order to
determine the mass change due to the predicted loss of a thiol group on the modified cysteine of the
peptide. The calculated molecular weight of the unmodified peptide sample was 746.37Da and based on
the deconvoluted mass spectrum a peak of 746.37Da was noted (Figure 18A and B). Dr. Dyanne Brewer
was then able to further analyze the collection of mass peaks and generate a correct control sequence
of LCTPSRA (Figure 18C).
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Figure 18: Electron Spray Ionization Mass Spectrometry (ESI-MS) of control peptide LCTPSRA at a
concentration of 2mM. Peptide suspended in water. Spectroscopic analysis of sample conducted at the
Advanced Analysis Center in the University of Guelph by Dr. Dyanne Brewer. Ionization polarity for
sample was positive. (A) Mass spectrum for the control peptide -LCTPSRA- generated via time of fight
measurement (TOF) which was deconvoluted to show a peak mass signal at 746.37Da. (B) Mass spectra
of control peptide for each of the amino acids overlaid on a single spectrum for sequencing. Each peak
was further labeled based on its intensity and charge, shown as ymax value and b value in (C).
Since the data was sufficient for the characterization of the known peptide substrate, a similar
condition and analysis was conducted for the unknown putative product of the reaction. A mass
spectrum was generated, and subsequent sequencing was accomplished (Figure 19).
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Figure 19: Electron Spray Ionization Mass Spectrometry (ESI-MS) of putative modified peptide product
from the enzymatic reaction. Peptide sample was flash-frozen directly after 16-hour reaction.
Spectroscopic analysis of sample conducted at the Advanced Analysis Center in the University of Guelph
by Dr. Dyanne Brewer. Ionization polarity for sample was positive. (A) Mass spectrum for the putative
modified peptide generated via time of fight measurement (TOF) which was deconvoluted to show a
peak mass signal at 744.36Da. (B) Mass spectra of the modified peptide for each of the amino acids
overlaid on a single spectrum for sequencing. Each peak was further labeled based on its intensity and
charge, shown as ymax value and b value in (C). Gray background for better clarity.
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Surprisingly, the data from the mass spectrometry of the modified peptide sample had a peak
mass signal at 744.36Da. This was a mass loss of 2.01Da that was attributed to the loss of two hydrogen
atoms from the serine residue of the peptide substrate. The reaction of an FGE with a serine residue can
produce an oxoalanine or formylglycine residue by oxidation to the carbonyl group of the serine in the
peptide. This was not anticipated as the removal of a thiol group from the cysteine residue would result
in a molecular weight of 728.77Da, however the mass calculated from the cysteine remained
unchanged. This result caused for further investigation into the potential for a serine modifying FGE
instead of the previously assumed cysteine modifying function.

3.5.3.4 – Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Further analysis of the enzymatic reaction for TDE2714 was conducted via TLC and was then
analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The technique was used
in order to determine any changes in polarity already demonstrated by the peptide TLC. LC-MS/MS
analyzes small molecules and their polarity differences by liquid chromatography that is then coupled
directly to a mass spectrometer for peak analysis(141). This allowed for the direct mass analysis of peaks
found in the liquid chromatography. ESI-MS/MS was chosen for the analysis of samples that were
isolated from the TLC plate. The samples analyzed included a control sample (LCTPSRA), a crude directly
flash-frozen modified peptide sample, and a purified modified peptide sample. Each of these samples
were run through a Poroshell C18 LC-column coupled with a positive ionization electron spray mass
spectrometer. The subsequent mass spectrum was generated for all three samples (Figure 20).
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Figure 20: Mass spectrum of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the
three peptide samples after the TDE2714 enzymatic reaction. Each sample was flash-frozen prior to
analysis and placed through a Poroshell C18 LC-column for liquid chromatography. Mass peaks of
samples were analyzed via ESI-TOF-MS and compared for retention time as well as calculated mass. Top
spectrum was from the purified modified peptide sample, which had a peak of interest at 16.00 minutes.
The middle spectrum was from the crude unfiltered modified peptide sample, which also showed a peak
at 16.00 minutes. The bottom spectrum was from the control peptide LCTPSRA which showed a peak at
13.25 minutes which corresponded to the mass of the peptide itself.

From the LC-MS/MS data shown, the control peptide had two peaks were visualized by the
spectrum. The unmodified spectra had a peak at 13.25 minutes with a calculated mass of 746.37Da, that
correctly corresponded to the mass of the control peptide. Sequencing analysis also had the correct
LCTPSRA sequence. Therefore, the retention time was used as a standard for the other peptides. For
each of the modified peptide samples there were numerous peaks that, when analyzed, were made up
of various peptide fragments and a range of masses. However, further analysis revealed that a
prominent peak at 16.00 minutes had similar results to the mass of the modified peptide that had a
mass loss of 2.01Da. The longer shift in the retention time agreed with the TLC results as the change in
polarity would cause of the oxoalanine-containing peptides to slower out of the column. The increased
retention of the modified sample was due to the interaction with the hydrophobic stationary phase in
reverse-phase LC. However, the sequencing of the peaks for each of modified peptides were
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inconclusive as the oxoalanine was not found on the serine residue and also an extra carbon atom was
accounted for. In light of these results, it was determined that further analysis and replication for each
of the reactions is required and will be conducted in the near future.

4. Discussion
4.1 – Thesis Objective and Goals
The objective of the research project was to characterize three targets from T. denticola that
showed a significant fold increase in their transcription when in a dense monoculture (or biofilm)(75).
These targets were TDE0626, TDE1701, and TDE2714 and they were previously classified as hypothetical
proteins. The research focused on identifying their role in the pathogenicity of T. denticola by
structurally and functionally characterizing each of the targets. This was conducted based on the
premise that since these targets were found to be more prominent in T. denticola when in a disease
state, they may play an important role its nutrition and colonization. For each of the targets isolation,
expression, and purification were required in order to obtain structural and functional characteristics.
The general procedure conducted for structural characterization was the use of X-ray diffraction
analysis, while the functional characterization varied for each of the targets. The data and information
gathered was able to give insight into the purpose for the upregulation of these targets in the biofilm.

4.2 – Characterization of the Target TDE0626
4.2.1 – Bioinformatics
Since TDE0626 was classified as a hypothetical protein in various databases (NCBI, UniprotKB,
etc.), the establishment of a reasonable functional hypothesis was required. This was accomplished by
93

the use of various bioinformatics tools that showed a homologous function to known polysaccharide
lyases, specifically ones containing a β-helix motif. However, prior to the development of the functional
hypothesis, the genomic context revealed that within the neighborhood of TDE0626 is a putative ABC
transporter ATP binding protein and a co-chaperone protein GrpE, from the NCBI database and StingDB.
The identifications of these proteins within close proximity to TDE0626 may indicate its involvement in
the degradation system of polysaccharides in T. denticola. Studies into polysaccharide lyases, specifically
uronic acid active enzymes, showed close association with ABC-transporter proteins in the bacterial
system(142). The degradation of N-acetyl glycosaminoglycans has been known to be highly active in
pathogenic bacteria when invading and colonizing host tissues(143). Pathogens employ the use of ABCtransporter proteins to import the degraded host glycosaminoglycans (GAGs), that are then utilized for
pathogen nutrition, such as T. denticola(142). GAGs, such as heparin sulfate and hyaluronan, are
degraded via anti-β-elimination reactions that cleave the α-(1,4)-linked uronic acids to produce an
unsaturated hexuronic acid residue and a reducing end, by cell surface or extracellular polysaccharide
lyases(144). The putative function of TDE0626 was determined by the identification of a homologous
Cthe_2159 domain from C. thermocellum. Studies into the function of this domain revealed an ability to
bind to polysaccharides such as cellulose and polygalacturonic acid. To accomplish this binding, the
domain contained a parallel β-helix motif with the catalytic residues of lysine as the Brønstead base and
several aspartate residues for calcium binding(145). These features were reported by the crystal
structure to be similar to the features in the PL9 lyase family that is known to be able to bind to GAGs
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for degradation. However, the ability for the Cthe_2159 domain to bind and hydrolyze GAGs has yet to
be determined. In light of the domain identified, the conserved region mapping of TDE0626 had three
putative catalytic lysine residues (Lys-140, 198, and 460) that could be involved in GAG degradation. The
conserved mapping also had a number of highly conserved aspartate residues (Asp-54, 176, 221, 308,
309, 396, and 372), that in other polysaccharide lyases are known to coordinate one or more calcium
ions(146). In order for TDE0626 to be either a carbohydrate binding protein or a polysaccharide lyase,
the localization should be extracellular as the both cellulose and GAG degradation would be in the
extracellular matrix. The discovery of a signal peptide sequence, by PSORT and SignalP, led to the
hypothesis that TDE0626 was extracellularly localized. This supported the hypothesis that TDE0626 is
either an upregulated carbohydrate binding protein or a polysaccharide lyase involved in the
carbohydrate metabolism by T. denticola.

4.2.2 – Experimental Analysis of Functional Hypothesis
Due to the information gathered via bioinformatics that suggested TDE0626 to be either
carbohydrate binding protein or a putative polysaccharide lyase, functional characterization was
required and conducted. Prior to functional assays, TDE0626 was successfully recombinantly expressed
and purified to concentrations of 10-30mg/mL with relatively low amounts of precipitation. The
hypothesis of binding to polysaccharides, was tested initially by the binding of cellulose to the purified
enzyme. However, based on the previous work that showed some binding to cellulose and
polygalacturonic acid the conclusion made was that the Cthe_2159 domain may be more likely involved
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in the degradation of uronic acids. Furthermore, in testing TDE0626 with cellulose, there was no
noticeable change in degradation. If TDE0626 is a polysaccharide lyase, similar to the PL9 family, the
cellulose linkages would not be able to be cleaved as proper binding would not occur as polysaccharide
lyases catalyze the hydrolysis of the 1-4 glyosidic bond of GAGs. The cellulose would not be able to
effectively fit into the active site of TDE0626 and therefore would be unable to be hydrolyzed. The use
of cellulose as a potential substrate was due to it being an architectural element in the biofilm matrix
and was previously suggested to have a role in the dispersal or degradation of the biofilm itself(147).
However, based on the cellulose assay, there was no indication that TDE0626 is able to degrade
cellulose. This led to the further investigation of TDE0626 being more similar to the PL9 lyase family.

A more suitable experimental analysis for TDE0626 would be measurement of the potential
substrate binding with GAGs such as hyaluronan and heparin sulfate, that contain uronic acid subunits
and may be cleaved by TDE0626. Physiologically, the presence of these GAGs would be found in higher
concentrations in host mammalian tissues and so pathogenic bacteria would be able to access the host
polysaccharides for the use in biosynthesis of essential compounds and nutrition(148). Like-wise, studies
showed that these GAGs can increase the formation of biofilms which then can progress the infection of
the pathogen(149). Within mixed biofilms produced by the pathogens such as the red complex, there
are GAGs also present called extracellular polymeric substances (EPS) that can be broken down by
polysaccharide lyases in order to promote dispersal as well as the spread of toxins deeper into the
tissues(12). In order to test this alternative function of TDE0626, the putative enzyme was treated with
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isolated samples of biofilm produced by the mixed culture of the red complex. The results from the
experiment were inconclusive was there did not appear to be any detected degradation of the biofilm
by TDE0626. From the experiment, there appears to be no activity on the GAGs within the biofilm;
however, there may not have been a large number of GAGs present within the biofilm samples used.
The number of GAGs within the isolates were not measured prior to treatment with TDE0626. Further
analysis for the lyase function of TDE0626 with either purified hyaluronan or heparin sulfate will be
conducted. Likewise, treatment of biofilm isolates from the red complex with known compositions of
GAGs and other polysaccharides will be conducted.

4.2.3 – Structural Characterization of TDE0626
Unfortunately, attempts to crystallize TDE0626 were unsuccessful despite the large amounts of
protein produced. During purification, low amounts of precipitation did occur, but it was possible to
obtain high concentrations upwards to 30mg/mL. Initial crystal screening using the sitting-drop vapour
diffusion was not able to generate crystal formation in a wide range of crystallization conditions. Further
attempts to crystalize the protein was conducted by varying conditions where the protein drop seemed
to be in a metastable condition. The state of protein called the metastable zone, it is a supersaturated
state of protein in a solution in which no nucleation points may occur. It is only when the optimal
conditions are found that the condition shifts to a nucleation state and forms nuclei. This can then be
grown with more protein in the metastable zone to make larger protein crystals(150). There arose a few
conditions that were believed to be within the metastable state and so the concentrations of the
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components were fluctuated. These conditions did not produce crystals, however, and so a different
approach to crystallization will need to be conducted. The addition of GAGs at low concentrations may
improve crystallization as this may allow for the rigid binding of the enzyme to a substrate and decrease
its motion within the solution(151). In addition, the addition of organic solvents may be required to aid
in the crystallization of TDE0626 by decreasing the amount of aggregation within the protein drops.

4.3 – Characterization of Target TDE1701
4.3.1 – Bioinformatics Analysis
Initial information gathered of the transcription of TDE1701 showed that there was no predicted
association to the neighbouring genes of T. denticola, based on StringDB. The only association with a
gene was with an upstream serine/phosphate phosphatase (TDE1698) however, there was no predicted
operon or gene cluster identified from the NCBI or KEGG database. Further investigation into the KEGG
database revealed two predicted paralogs in T. denticola which were bacteriocin-type signal sequences.
This was an interesting discovery as these sequences are known to aid in the pathogenicity of bacteria
within a biofilm infection(152). The use of bacteriocins by an organism has been known to suppress the
growth and proliferation of competitive species within a biofilm, such as the oral streptococci ssp(153).
Pathogens such as T. denticola produce these bacteriocins and secrete them into the biofilm in order to
increase the colonization of the pathogen into the subgingival plaque of a host(154). The production of
bacteriocins in pathogens require three main gene products; bacteriocin, a bacteriocin ABC-transporter,
and a bacteriocin immunity protein(154). The prediction of TDE1701 identified that it potentially could
be part of the bacteriocin ABC-transporter as a bacteriocin precursor sequence was discovered that
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contained a small bacteriocin signature of two glycine residues beside each other. This signature is often
referred to as a double-glycine-type leader peptide and is involved in the secretion of the
bacteriocin(155). It is with this sequence that bacteriocin can be produced and further exported from T.
denticola via the use of an associated ABC-transporter protein(156). Further evidence to support the
putative bacteriocin function of TDE1701 was shown in the transcriptomic analysis, which suggested
that when T. denticola is in a mature biofilm, the expression of TDE1701 is increased(75). This increase
in expression of a putative bacteriocin would allow for the suppression of competitive bacteria and
therefore allow T. denticola to have an increased pathogenicity within the host.

The concerning information gathered from the bioinformatics analysis was that TDE1701 was
predicted to be 50% intrinsically disordered based on Phyre2 homology modelling. This was also
highlighted by the lack of homologous proteins predicted or similar identified motifs, using other
domain searches. TDE1701 was predicted to either contain novel folds or motifs, however Phyre2
suggested TDE1701 to be a disordered protein, and for this to be true, the protein would be difficult to
crystallize. TDE1701 as a bacteriocin-like protein could be used in bacteriocin activity that could explain
the prediction that this protein is secrete into the biofilm. The prediction was caused by the
identification of motifs that were synonymous with secreted extracellular proteins by localization
software such as CELLO and PSORT. Based on the conserved sequence mapping onto protein models, it
seemed that there was a low conservation of residues within TDE1701. However, further comparison to
known bacteriocin associated proteins suggested the double-glycine-leader sequence (used to produce
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lantibiotic bacteriocins) present in TDE1701 may be able in the Gram-negative T. denticola in targeting
Gram-positive pathogens that can be present in the periodontal pocket(151,152).

4.3.2 – Structural Characterization of TDE1701
In spite of the prediction that TD1701 was a disordered protein, recombinant expression and
purification was successfully accomplished. The purity of the isolated protein was shown to be relatively
high and was able to yield a concentration upwards to 10mg/mL. This was an interesting result as a
disordered protein should not give such a good reading from DLS. The results of the DLS that yielded a
monodispersed sample could be caused by the aggregation of the protein in the solution by the high
concentration of 5mg/mL. This meant that the prediction of a 50% intrinsically disordered TDE1701 was
most likely not the case.

Initial crystallization of the protein was successful using sitting-drop vapour diffusion and
screened over a variety of conditions. There were two conditions which showed the formation of
protein crystals after approximately three weeks of incubation at 18oC. The first of these conditions was
found in solution E3 of MCSG-1, which contained; 0.05M magnesium chloride, 0.1M HEPES: NaOH pH
7.5, and 30% (v/v) polyethylene glycol methyl ether 550. The morphology of the protein crystals were
spherulites, which are small crystals that originate from the same nucleation point(159). These protein
crystals can yield a higher mosaicity during the X-ray diffraction analysis due to the difference in planes
from the crystals(160). However, there was also a larger protein crystal which formed separate from the
spherulites which would yield better quality and more complete diffraction data.
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Similarly, there was another condition from the initial crystal screening, which yielded a large
amount of protein crystals. The condition of the second crystallization was found in C10 of the PACT
screen, which contained; 0.2M magnesium chloride, 0.1M HEPES: NaOH pH 7.5, and 20% w/v
polyethylene glycol 6000. The formation of these crystals seemed to also be a form of spherulite as all
the crystals stemmed from a single extended line. Based on the assumed diffraction quality yielded by
the protein crystals, only one of the crystals was selected from the condition which was hypothesized to
have a low mosaicity. This was based solely on the morphology of the crystals, however this did not
mean there would be good quality diffraction.

Further attempts to replicate the crystallization of TDE1701 were unsuccessful when each
condition’s components were varied in a hanging drop vapour diffusion crystallization method. The
larger volume and adjustments of the precipitating agents (polyethylene glycol) were not able to
crystallize TDE1701. This may have been due to the difference in the diffusion rate from the hanging
drop instead of the original sitting drop, which has previously been reported to affect the crystallization
of a number of proteins(161). In order to further crystallize TDE1701, it was imperative that optimization
of conditions be conducted using the sitting drop vapour diffusion.

For definitive functional identification, X-ray diffraction analysis of the crystalized TDE1701 was
conducted using the two best selected protein crystals. The diffraction data collected by the Canadian
Light Source synchrotron revealed a high-resolution dataset that was truncated at 2.40Å and a
completeness of 100%. This data was processed and showed a P212121 orthorhombic space group.
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Molecular replacement was conducted to generate a structural model of TDE1701. Initial refinement
used Refmac5 software to generate the model TDE1701. However, based on the data generated during
molecular replacement and refinement, the Rwork/Rfree values for the model was 0.48/0.53. This was very
high for a refined structural model and shows that the data generated by the model building did not
match the diffraction data(130). It was therefore determined that the structural model for TDE1701 was
not an accurate representation of the true protein structure. Another method which will be explored is
the use of selenomethionine containing TDE1701 crystals for MAD experimental phase determination,
rather than molecular replacement.

Functional analysis of the purified TDE1701 sample has not yet been conducted. However, it has
been hypothesized that testing for the presence of TDE1701 within a mature mixed culture biofilm from
the red complex may give indication that it is a bacteriocin-associated factor. The testing will be
conducted similar to the testing conducted by tailocins, which are high molecular weight bacteriocins
from phages(162).

4.4 – Characterization of Target TDE2714
4.4.1 – Bioinformatics
The development of a working hypothesis for the function and role of TDE2714 in T. denticola
was accomplished via bioinformatics. The initial data gathered revealed three putative roles for the
function of TDE2714 that were a calcium-dependent carbohydrate binding protein, a large diversitygenerating retroelements (DGR), or a hemolytic formylglycine-generating enzyme. In order to best
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identify the true function of TDE2714, more context would be required via further use of bioinformatics
tools.

Based on the data collected from the KEGG database, there were 16 paralogs identified in T.
denticola that all had a putative formylglycine-generating enzyme (FGE) function. Since there are quite a
few predicted FGEs in T. denticola, it is imperative to look to this as being the potential function of
TDE2714, as sequence alignments with the paralogs revealed a number of conserved signatures in
TDE2714 and the 16 others that are unique to FGEs. These signatures include, the RLPTXAEWE region,
highly conserved GN region, and a cluster of cysteines near the C-terminal. The known role of FGEs
within both Eukaryotes and Prokaryotes is to modify either an active site cysteine or serine residue
within a type I sulfatase(88). These sulfatases are important for bacteria due to their involvement in
scavenging sulfates as a source of sulfur(137). This has been known to occur within the endoplasmic
reticulum of Eukaryotes and either the cytoplasm or periplasm in Prokaryotes(163). However, based on
the results from CELLO and PSORT for TDE2714, the predicted localization was extracellular. This means
that there may exist other functions for FGEs in T. denticola.

Cystalysin is a hemolytic protein expressed in T. denticola that has been known to generate H2S
extracellularly as a by-product of producing pyruvate from cysteine residues of blood cells(164). This
generation of H2S within infected host tissues has been shown to be in high concentrations and exhibits
hemolytic properties similar to hemolysins(164). The hemolysis of tissues can be important for T.
denticola as it may aid in the further colonization into host tissues, as well as the access to nutrients.
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Interestingly, the formation of a formylglycine residue from a cysteine is also known to generate H2S by
the removal of a thiol group(165). Based on the predicted FGE function of TDE2714, it may be possible
that this enzyme also exhibits hemolytic activity on host tissues, as it is exported from the bacteria into
the surrounding tissues. Further evidence for this was the identification of an encoded hemolysin
(Tde2410) that shares genetic context with Tde2714 based on the StringDB database. This suggests that
similar associated functions may be present or similar involvement in the pathogenicity of the bacteria.

Homology modelling of TDE2714 using software, such as Phyre2, suggested two alternative
functions for the protein that were either a diversity-generating retroelement (DGR) or a calciumdependent carbohydrate binding protein. The sole link between these two predictions was the T.
denticola Variable Protein 1, which has been found to contain a large C-type lectin domain which bears
resemblance to bacteriophage DGRs(166). The primary sequence identity was high at 45% identical
which represents a high likelihood that either TDE2714 possesses a similar function and role or contains
similar structural elements such as motifs. The identification of these DGRs within bacteria have been
known to aid in the mutations of surface proteins which can lead to massive biophysical changes in the
proteins. This utilized by the bacteria to avoid detection from the host immune system and increase the
pathogenicity of the bacteria(167). The C-type lectin domain can be used as a scaffold for massive
mutations for immunoevasion(106). This may be explained in TDE2714 as it was predicted to be
extracellularly localized which can then be mutated to aid in immunoevasion. However, based on
conserved residue mapping of closely related proteins from all domains of life showed a highly
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conserved region that is present in all FGE-sulfatase modifying enzymes (RLPTQAEWE). The putative
function of TDE2714 was a hemolytic formylglycine generating enzyme that bears structural
resemblance to diversity generating retroelements.

The results from the site-directed mutagenesis of TDE2714 to the C637A mutant were
perplexing. Based on multiple sequence alignments and conserved residue mapping, the active site
cysteines should have been located within the same proximity as previously identified FGEs, such as
2AIK from S. coelicolor. For all cysteine modifying FGEs, the catalytic residues have been reported to be
two cysteines that form a disulfide bridge and are involved in the oxidative removal of a thiol from an
active site cysteine in a type I sulfatase(107). The change of the Cys-637 to Ala-637 should have reduced
or eliminated the function of TDE2714 on the peptide substrate -LCTPSRA-. However, the same nonpolar product was visualized for the mutant after incubation and TLC. This meant that the C637 residue
is not catalytically important and the other cysteines are potentially involved in catalysis. Investigation
into generating mutants that have all the cysteines changed to alanine residues is underway.

4.4.2 – Functional Characterization of TDE2714
The functional analysis of TDE2714 was conducted with two different cases in mind, either
TDE2714 is a carbohydrate-binding protein, or it is an formylglycine-generating enzyme. These two cases
for the function were determined by the fold-recognition software and homology modeling of TDE2714.
The first case was tested that TDE2714 is a carbohydrate-binding protein as it was homologous to a Ctype lectin protein with a sequence identity of 45%. The initial experimentation of TDE2714 were unable
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to confirm the first case. This was seen in the C-PAGE results were there was no identified mobility
change in TDE2714 when incubated with polygalacturonic acid. If TDE2714 were able to bind to the
polysaccharides, there would have been a conformational change in the enzyme that would had
affected its mobility through the gel, by making a more rigid condensed structure. This was not seen in
the results and so the putative carbohydrate binding of TDE2714 was dismissed. Further investigation
may be conducted for this function however, the results point towards TDE2714 being a formylglycinegenerating enzyme.

For testing the hypothesis of TDE2714 being an FGE, a peptide substrate was generated that
contained the sulfatase motif sequence of -LCTPSRA-(168). This peptide sequence was designed based
on the most studied and well-characterized type of FGE, which is a cysteine-modifying FGE in both
Eukaryotes and Prokaryotes(169). The cysteine at position 2 in the peptide was anticipated to be
converted to a 3-oxoalanine residue (formylglycine) by oxidation with TDE2714. Initial testing in a
reduced environment generated a noxious rotten eggs odor, which was suspected to be from the
production of H2S gas. This however was not able to be confirmed as the gas and the smell could have
been contributed by DTT within the reaction. Visual quantification of the potential enzymatic reaction
was conducted by a peptide TLC protocol in which the same testing with the peptide substrate was done
and spotted on a TLC plate. The anticipated spots of the enzyme and the substrate revealed a third spot
was identified to be less polar than the substrate. Based on this, it was plausible to assert that the
oxidation reaction of a cysteine to a formylglycine was successful based on the product being less polar.
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The removal of the two hydrogens or thiol group of the peptide would have yielded a less polar product
or a formyl group its place. The third spot most likely was product generated by the enzyme and this was
due to the results of a time-course TLC. Over the course of time, there was an increase in the intensity of
the non-polar spot and gave indications that this may be caused by the enzyme turning over more
product. However, enzymatic kinetics were unable to be calculated based on the intensities of the spots
on the TLC plate, but these results were more encouraging in comparison to the carbohydrate binding
assays.

The results from the ESI-MS for both the modified and the unmodified peptides were able to
give an expected substrate molar mass of 746.37g/mol was detected and sequenced to show the correct
LCTPSRA sequence. This was encouraging as the methodology was able to give a reproducible control.
However, using the same parameters of mass spectrometry for the modified peptide product, a new
molar mass was detected of 744.36g/mol which was a 2.01g/mol difference from the substrate. The loss
of the equivalent of two protons could have been anticipated that there were two types of mechanisms
for Prokaryotic FGEs(170). The widely studied cysteine modifying that removes a thiol group from an
active site cysteine, as well as a metal dependent serine modifying FGE similar to AtsB from K.
pneumoniae. This enzyme uses two auxiliary iron-sulfur sites and a radical s-adenosylmethionine (SAM)
to catalyze the oxidative removal of two protons of a serine residue in a sulfatase. The sequencing
results of the mass spectrum for the modified peptide showed modified sequence of -LCTPSRA- as the
serine residue on modified peptide substrate was shown to have lost 2.01g/mol. These results were not
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anticipated as the experimental design was to modify the cysteine residue and was based on the
similarities of TDE2714 to cysteine modifying enzymes. A cysteine modification would have yielded a
mass difference of 18.11g/mol by the removal of a thiol group. Based on the data, TDE2714 as a cysteine
modifying FGE was dismissed.

As stated before, Prokaryotic FGEs can also modify active site serine residues within type I
sulfatases(171)(170). The reaction has the ability to produced H2 gas instead of H2S during the oxidation
of the serine(172). The resultant mass difference would be 2.02g/mol. Using iron-sulfur prediction
software such as MetalPredator(173), it was determined that TDE2714 did not contain the known
residues required for iron-sulfur binding as TDE2714 lacked the sufficient residues to coordinate with
iron-sulfur clusters. This caused for the hypothesis, that TDE2714 is not an iron-sulfur containing FGE
however it has the capability to modify serine residues. However, H2 gas has been detected in affected
periodontal pockets and has been known to exhibit similar hemolytic activity(174)(175). This give
credence to the potentially new claim that there exists a seine modifying FGE that operates without the
use of iron-sulfur clusters and a radical SAM. Based on the information gather thus far, TDE2714 may be
an extracellular hemolytic serine FGE in T. denticola.

Since T. denticola is an obligate anaerobe, the proposed mechanism for cysteine modifying FGEs
cannot be used for TDE2714 as there would be no oxygen available for the enzyme to use. The proposed
mechanism for TDE2714 would potentially be a hybrid of the two known mechanisms, such as the thiol
or hydroxyl binding of a substrate cysteine or serine, followed by a nucleophilic attack on the proton of
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side chain carbon by an adenosine-based free radical. This then could be utilized to make 5'deoxyadenosine and new radical can either form directly into the 3-oxoalanine or a thioaldehyde
intermediate, then to the 3-oxoalanine (Figure A11 in Appendix).

In light of this new hypothesis of TDE2714 that there may have been errors in the data analyzed,
as the experiment was designed for cysteine active FGEs and not serine active, and so further attempts
were conducted using liquid chromatography-tandem mass spectrometry (LC-MS/MS). However, the
data was only conclusive for the peptide substrate that showed a similar mass of 746.37g/mol to the
ESI-MS experiments. The modified peptide samples sent showed a peak at had a longer shift in the
elution time compared to the unmodified substrate. This was expected for the conversion of a cysteine
or serine to an oxoalanine, as the peptide would become less polar and be able to elute slower out of
the reverse-phase column. However, the MS/MS spectra and sequencing revealed an extra carbon atom
that was calculated for the modified peptide sample at the 3-oxoalanine site of the serine. This unusual
addition of a carbon atom is a cause of concern as there may have been more than one unexpected
reaction that may have occurred during either the enzymatic reaction or the ESI-MS. Based on this,
further analysis will be conducted to correctly identify the potentially modified peptide product via 2dimensional nuclear magnetic resonance (2-D NMR) such as employing correlated spectroscopy (COSY)
NMR.
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4.4.3 – Structural Characterization of TDE2714
In order to determine the correct function of TDE2714, structural characterization was also
required to generate a working model that could be used in comparison to the predicted homologous
proteins. This was accomplished by the successful recombinant expression and purification of TDE2714
which was able to yield concentrations ranging from 10mg/mL to 25mg/mL with high purity. The initial
crystallization showed the formation of small plate crystals which were determined not to be ideal for Xray diffraction analysis based on the assumed high mosaicity during the diffraction. This protein
crystallization condition (0.2M NaNO3, 20% (w/v) polyethylene glycol, and 50mM Tris-HCl pH 8.0) was
optimized by varying the concentration of PEG from 19.6-20.2%. The resultant crystals were shown to
be larger and bulkier, which was found to be promising for X-ray diffraction analysis. The diffraction
analysis for the optimized protein crystals resulted in a 2.71Å resolution with a calculated primitive
monoclinic P21 space group for the asymmetric unit. However, based on the statistics generated during
processing of the diffraction data, the I/σI value (intensity/error in intensity) was shown to be 2.2 in the
outer shell which was low for the calculated space group. This meant that further diffraction analysis
was required such phase determination using selenomethionine crystals. These crystals were
successfully grown in the same optimized conditions for TDE2714 and also sent for selenium-MAD
analysis. The data obtained did not successfully give sufficient phase information for the generation of a
working structural model of TDE2714 and so further crystallization and diffraction will be required.

110

5. Conclusion
For this research project, three upregulated gene products, TDE0626, TDE1701, and TDE2714,
from T. denticola were investigated for their role in aiding the pathogen to progress chronic periodontal
disease. The main objectives of the research were to structurally and functionally characterize these
gene products in order to better understand how T. denticola is able to progress chronic periodontitis.
Not all of the main objectives were accomplished for all of the targets in the study, however the results
of each of the targets was able to satisfy some portions of the objectives.

Initial bioinformatics analysis suggested the putative functions of the targets to be a N-acetylglycosaminoglycan degrading polysaccharide lyase, a bacteriocin-like protein, and a formylglycinegenerating enzyme, respectfully. Each of these suggested functions have been known to play a role in
the pathogenicity of various microorganisms and this was investigated for T. denticola. Based on the
mixed biofilm degradation assays for TDE0626, no change from the treated and untreated samples was
found. Further assays will be conducted to confirm whether TDE0626 can degrade N-acetylglycosaminoglycans solely or within a biofilm. The mass spectrometry for the reaction of TDE2714 was
able to modify a sulfatase consensus sequence (-LCTPSRA-) to an oxoalanine residue at the serine site.
This was not anticipated based on the general design of the assay however further validation of the
results will be conducted via LC-MS/MS in the absence of salts. Furthermore, TDE2714 will be treated
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with a variety of peptide substrates that lack either cysteine or serine residues or both completely. The
analysis will also be conducted by the generation of mutants at the conserved ‘-RLPTQAEWE-’ region of
TDE2714. The development of a functional assay for TDE1701 will be conducted after more structural
data can found. Based on the functional results, the function of TDE0626 was able to be better
hypothesized as a polysaccharide lyase that may be involved in the nutrition of T. denticola. Whereas,
the function of TDE2714 was able to be identified as a formylglycine-generating enzyme that can
catalyze the oxidative conversion of either a cysteine or serine residue. Unfortunately, the function of
TDE1701 has yet to be determined however, the initial results from bioinformatics suggests a
bacteriocin function.

Two of the three targets (TDE1701 and TDE2714), were successfully crystallized, and initial X-ray
diffraction analysis was conducted. Both of the targets showed relatively good crystallographic data
based on data collection and allowed for attempts for generate structural models. For TDE1701, the
data showed a high resolution of 2.40Å in the outer shell with an acceptable I/σI of 2.2 and CC1/2 of
0.823. For TDE2714, the data showed a high resolution of 2.75Å in the outer shell and I/σI of 2.2.
However, in both cases the Rmerge values were close to 1.0 (1.089 for TDE1701 and 0.819 for TDE2714)
which seemed to be of concern for the datasets. Molecular replacement was unable to generate an
acceptable structure which could be representative of the ‘true’ protein structure. Selenomethionine
anomalous diffraction experiments was successfully conducted for TDE2714; however, the data was
unable to improve the prior collected data for TDE2714. Attempts to grow selenomethionine containing
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crystals or improve the quality of crystals will be conducted for both TDE1701 and TDE2714.
Crystallization attempts will also be conducted for TDE0626 for structural characterization. The structure
of each of the enzymes has yet to be determined however for TDE1701 and TDE2714, they are on track
to being structurally characterized.
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Appendix
Table A1: Summary table of Dynamic Light Scattering for all three targets, TDE0626, TDE1701, TDE2714.
Table showing peak scattering with highest percent mass. Each sample was concentrated to 5mg/mL
prior to DLS analysis. Target proteins all suspended in anion exchange buffer (either 50mM Tris-HCl pH
8.0 or 100mM glycine-NaOH pH 9.6).
Target
TDE0626
TDE1701
TDE2714

Radius (nm)
3.433
3.113
5.247

%Pd
25.6
29.9
30.1

Mw-R (kDa)
60
48
163

%Intensity
6.6
22
97.2

%Mass
96.7
99.2
99.8

Table A2: Crystallization conditions for the optimization of TDE2714 using purified protein in Tris-HCl pH
8.0. Hanging drop vapour diffusion was in a 24-well tissue culture plate with concentrations of TDE2714
at 12, 14, and 16mg/mL. Adjusted polyethylene concentration from 19.6% to 20.2% (w/v). There was an
addition of two organic solvents (glycerol and ethylene glycol). Buffering pH ranged from 7-8 based on
pH test of condition. Plates were incubated at 18oC for one month. Star beside well number indicates
large protein crystals.
Well

Organic solvent

*A1
A2
A3
A4
A5
A6
*B1
*B2
B3
B4
B5
B6
*C1
*C2
*C3
*C4
C5
C6
D1
D2
D3
D4
*D5
D6

Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol
Ethylene Glycol
Ethylene Glycol
Ethylene Glycol
Ethylene Glycol
Ethylene Glycol
Ethylene Glycol

Concentration
(% v/v)
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
5.0
5.0
5.0
5.0
5.0
5.0

Buffer
Tris pH 7
Tris pH 7
Tris pH 7
Tris pH 7
Tris pH 7
Tris pH 7
Tris pH 7.5
Tris pH 7.5
Tris pH 7.5
Tris pH 7.5
Tris pH 7.5
Tris pH 7.5
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8
Tris pH 8

Concentration
(M)
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05

Polyethylene
Glycol
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350
3350

Concentration
(% w/v)
19.6
19.8
20.0
20.0
20.0
20.2
19.6
19.8
20.0
20.0
20.0
20.2
19.6
19.8
20.0
20.0
20.0
20.2
19.6
19.8
20.0
20.0
20.0
20.2

Salt
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3
NaNO3

Concentration
(M)
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
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Table A3: Predicted operons for TDE0626 and TDE1701 from DOOR2 database. Each target operon was
predicted a data mining classifier that identifies parameters such as intergenic distance, neighborhood
conservation and phylogenetic distance. A confidence score was given for each operon however no
additional information about the operons were provided.
Gene
TDE0623
TDE0624
TDE0625
TDE0626

Gene
TDE1700
TDE1701

Product
Precorrin-3B C17methyltransferase
Precorrin-6X
reductase
ABC-transporter
protein
Hypothetical
protein
Product
Hypothetical
protein
Hypothetical
protein

TDE0626 Operon
Start (bp)
655923

End (bp)
656645

656642

657400

657393

658163

658230

659744

TDE1701 Operon
Start (bp)
1758180

End (bp)
1758287

Confidence (%)

1758280

1759407

47

Confidence (%)

100

Table A4: Fluorescence test scans for selenomethionine-containing TDE2714 crystals. Scans tested at CLS
for identification of anomalous signals. The anomalous scattering coefficients for both the peak and
inflections shown for all three test scans.
Scan
1
2
3

Peak (eV)
12665.7
12659.7
12716.7

Inflection (eV)
12667.7
12656.7
12656.7

f’’ peak
3.62
4.53
3.10

f’ peak
-5.74
-7.53
-5.39

f’’ inf
1.77
1.65
0.91

f’ inf
-8.01
-8.62
-6.48
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Figure 21: Conserved mapping of multiple sequence alignment from COBALT of TDE0626 primary
protein sequence. Conserved mapping was generated by ConSurf which was used to show regions of
high conservation from a scale of 1-9, where 9 is highly conserved among all polysaccharide lyases. Data
showing a highly conserved region (DGIDSNG) at positions 369-375 for TDE0626. Predicted functional
elements label with a red f and structural elements labelled with a blue s.
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Figure 22: Conserved mapping of multiple sequence alignment from COBALT of TDE1701 primary
protein sequence. Conserved mapping was generated by ConSurf which was used to show regions of
high conservation from a scale of 1-9, where 9 is highly conserved among all homologous proteins. Data
showing relatively low sequence conservation and one region of average conservation at positions 103108 (DNGDDE) for TDE1701. Predicted functional elements label with a red f and structural elements
labelled with a blue s.
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Figure 23: Dynamic light scattering plot for 5mg/mL TDE1701 in 50mM Tris-HCl pH 8.0 after anion
exchange chromatography. Analysis depicts scattering profile as a measurement of predicted % mass
versus the calculated average particle radius (nm). The mass distribution for the protein sample shown
as three distinct peaks. Each peak shown with corresponding; radius, percent polydispersity (%Pd),
predicted molecular weight based on radius, percent intensity, and percent mass. 20 images were taken
of the scattering profile every 5 seconds and averaged.
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Absorbance at 280nm

Volume (mL)

Figure 24: Chromatograph of anion exchange chromatography from purified TDE1701 in 50mM Tris-HCl
pH 8.0. Protein sample volume added to the GE HiTrapTM Q FF 5mL column was 250mL based on an
initial volume of 175mL, for two full cycles over the column. Miliabsorbance units (mAU) at 280nm and
Conductivity (mS/cm) were below a value of 2.0 prior to sample application. Flow rate set to 5 mL/min.
The alarm for the delta column pressure maxima was set to 0.5MPa and minimum at 0.0MPa. Wash
buffer used was 50mM Tris-HCl pH 8.0 and elution buffer, for salt gradient elution was 50mM Tris-HCl
pH 8.0 with 1M NaCl. Peak fractions were at fractions 15-32, which corresponded to the NaCl
concentration of 337mM. Blue line represents absorbance reading at 280 and dark brown line
represents conductivity.
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Figure 25: pET21a-d(+) vector sequence map. Plasmid map showing all restriction enzyme cut sites as
well as inducible lac operon and multiple cloning site. Cloning and expression region shown with pET21b
sequence highlighted
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>TDE0626
EDRFPIGRMEVNLKTPVQRDTSKLFSDKDFKTEYGSSKVVSVNLSALSGISAKGLTVNGNTVTINEGGQYIISGSLNDGQII
VDAPDNDEVHLILDNADISNSSMPVIYAKKAGKMLITLAKGSKNKLNVNGKFADSDAGKTNAVIFSQTDLTLNGTGELN
IESKYGSGIVSKKDLRVTGGSFTVSASKHALKGCDNVSIADGKFTLTAGKDGIHSENEENAESGNIYIKNGEFTINAASEAL
DAINDITIDGGYINIAKADEGMEALTININGGKIMVVSSDDGLNASYSDKEEIEAKLSGTALTDNSSKKTEKKGPPVLSESA
ASTYVNITGGEVTINSQADGIDSNGSVYVSGGKVNILGPVSDGDAALDYDLTALISGGEFIASGSRGMVQGFSDKSTQA
SFIANFSKTVKGEVIVSDSSGAVILKTNQDKDFQSIVVSSKGLKVGETYKITAGGQTLTVKMDSISVGDNMHKRR
>TDE1701
MDDLMNVVGGDTTINTRGIDVCNPSPEPDYIIDDDGNHHHAPSPSPTNPKPAPGTGNPGNPPNTGNDGDGGGDSK
DPTEDTPSDPGNPVNDDGGNGSSGGTPDNGDDETGGNTNLPTDDDGDIGNGSVGNGGQTTTPPAANINTTQTTQA
ADVSPKPVSPAERARSILANLTNPIEQTVNAKTGCKNDMLAAYYDDKLTNKKLSFDASYKEVQDDLPMQKDKNGKVIY
PNTCKYNSTIGAVRLSGYTYKDDLTKEDVEKITNKAVSSKKCKLHTDVIKEVFGLDAVYYEIPAGLSEKELKALVGDNPAMI
RFPQRAFWGNDKLPEDGEHGIGYVNGGFIEPYMGRHGESWKDVRGARSTADFTSNLGGLYFEIKK
>TDE2714
MIDSWHLGTDESAPELKDTDTFYTNAVVFVKSRPDLPDLSSIQGTGDQVKITLAVTLEEGGAILGPKSISVNKGTRWNSV
LKTYAKAALKVKYGFQCNGWKKNGNTVNDTYTFDDDTTIFAELEDMRINITVKGDSNVSVPDSTPLVVLSGRKWQDIK
ELAAGRIQVSDPSNIAVTAWHRGESASAPVLTDEYEFKKAEGQNRTVYAKTGDRRITLTVTYGSGSGTPATAGTITIYDG
DEWHNVQKQVAPLVSVPEDHSIHWYLDNAGGELINFFYTFKASDGNARTVYARVSPPIQLTVTYGRVTGATVTIGTVT
THHRRLWYSVQNEIKYKYPLLSNTEVEWHWNDKNGALISDTYEFDAGNVPSNTVYAFVRPKIITYYGGLRYIAPIGSNGS
YEDYNMKKIDAVTDGYVGGDAYHYVYNDPHKVSLTAYRIGTTEVTQELYELVMAHNPSYFQGSSHPTASGESQEKRPV
EQVSWFDAIAFCNELTRCCYSLGEAQCVYTYNGHTYTVEDAQAHNVPVMDMSKKGFRLPTQAEWEWAAQSGTAW
QKWAGTNDEDKLSYYAWYDANEYGRTHQAGRKKANPFGLFDMSGNVSEWCWDWWIQTTPEGGTDPVGPLSGTN
RTTCGGGYSFFDSACCCAYRGLEEPDKNKDTTGFRIVCRYEF
Figure 26: FASTA protein sequences for all targets; TDE0626, TDE1701 and TDE2714. Custom genes and
optimized sequences ordered from GenScript in pET21b vector. Affinity tags not shown for any of the
sequences.
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Figure 27: Site-directed mutagenesis of C637A mutant of TDE2714 visualized by a 1%(w/v) agarose gel
and imaged with 0.5µg/mL of ethidium bromide. Lane 1 containing NEB 1kb DNA ladder. Lane 3
containing the PCR reaction with 5’-forward primer. Lane 6 containing the PCR reaction with 3’-reverse
primer. Lane 8 containing the PCR reaction of both forward and reverse primers.
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Figure 28: Cellulose binding assay for purified TDE0626 at 0.5mg/mL in 50mM glycine pH 9.6. Six
samples of cellulose were incubated with TDE0626 for 1h at 37oC. The concentrations of cellulose were
5, 10, 15, 20, 25, 50mg/mL. The filtered samples were visualized on a 12%(w/v) polyacrylamide gel and
stained with silver nitrate. Lane 1 containing the Precision Plus Protein™ Kaleidoscope ladder. Lanes 2-7
containing the supernatant after filtration for each of the samples. Lanes 8-13 containing the
resuspended pellets of cellulose after filtration.
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Figure 29: C-PAGE gel of TDE2714 at 5ng/mL incubated with 0.5%(w/v) polygalacturonic acid.
Polyacrylamide gel contained 15%(w/v) acrylamide and 1%(v/v) bis-acrylamide. Spot 1 contained
TDE2714. Spot 2 contained 5ng/mL BSA standard + polygalacturonic acid. Spot 3 contained TDE2714 and
polygalacturonic acid. Gel was imaged via silver nitrate, formaldehyde, and sodium carbonate.
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Figure 30: Thin-layer chromatography tests for wild-type TDE2714 and C637A mutant when incubated
with the sulfatase consensus sequences – LCTPSRA – at 37oC for 16h. A) wild-type TDE2714 peptide TLC.
Spot 1 contained 1mM peptide, 1mM DTT, and 50mM sodium phosphate pH 8.0. Spot 2 contained
0.1mM WT-TDE2714, 1mM DTT, and 50mM sodium phosphate pH 8.0. Spot 3 contained 1mM
peptide,0.1mM WT-TDE2714, 1mM DTT, and 50mM sodium phosphate pH 8.0. B) C637A mutant
peptide TLC. Spots 1-3 contained same components.
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Figure 31: Proposed mechanism of anaerobic FGE lacking iron-sulfur clusters with either a radical sadenosylmethionine or a similar compound. A precursor electron donor is required for the reaction to
commence. A catalytic aspartate would be required for the formation of the formylglycine (Fgly).
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Figure 32: Diffraction image of TDE2714 collected at CLS and visualized by iMosfilm. Image shown at 90o
during 0.2o oscillations over 720o rotation.
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